{"content":"<li class=\"n-box-item date-title\" data-end=\"1531454399\" data-start=\"1531368000\" data-txt=\"Monday, December 23, 2019\">Thursday, July 12, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3369855\" data-ts=\"1531448742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369855-j-and-j-slammed-4_69b-jury-verdict-in-missouri-cancer-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J slammed with $4.69B jury verdict in Missouri cancer case</a></h4><ul>     <li>The Missouri jury that <a href=\"https://seekingalpha.com/news/3369831-j-and-j-found-liable-cancer-case-ordered-jury-pay-550m\" target=\"_blank\">awarded</a> $550M to 22 women and their families who blamed ovarian cancer cases on asbestos in Johnson &amp;&nbsp;Johnson's (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) talc-based products later <a href=\"https://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit/jury-orders-jj-to-pay-4-7-billion-in-missouri-asbestos-cancer-case-idUSKBN1K234U\" target=\"_blank\">added $4.14B in punitive damages</a> against the company; JNJ <font color='red'>-2.4%</font> after-hours.</li>     <li>JNJ says it will appeal the verdict, calling it \"<a href=\"https://seekingalpha.com/pr/17215350-johnson-and-johnsons-official-statement-response-todays-verdict-st-louis-trial\" target=\"_blank\">fundamentally unfair</a>.\"</li>     <li>The company is battling ~9K talcum powder lawsuits with mixed success but says every verdict against it that has come from the St. Louis court that has been appealed \"has been reversed and the multiple errors present in this trial were worse than those in the prior trials which have been reversed.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369855\" data-linked=\"J&amp;J slammed with $4.69B jury verdict in Missouri cancer case\" data-tweet=\"$JNJ - J&amp;J slammed with $4.69B jury verdict in Missouri cancer case https://seekingalpha.com/news/3369855-j-and-j-slammed-4_69b-jury-verdict-in-missouri-cancer-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3369855-j-and-j-slammed-4_69b-jury-verdict-in-missouri-cancer-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369854\" data-ts=\"1531442349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369854-celgene-ups-dose-and-enrollment-in-mid-stage-study-of-bb2121-in-multiple-myeloma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myeloma</a></h4><ul><li>Citing the totality of the clinical data, Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) has <a href=\"https://www.sec.gov/Archives/edgar/data/1293971/000156459018016804/blue-8k_20180712.htm\" target=\"_blank\">amended the protocol</a> in its Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03361748?term=bb2121&amp;rank=1\" target=\"_blank\">KarMMa</a>, assessing CAR T candidate bb2121 in patients with relapsed/refractory multiple myeloma &#40;MM&#41;.</li><li>Specifically, the dose range has been increased to 15 - 45 x&nbsp;10<sup>7&nbsp;</sup>CAR T-cells from 15 - 30 x 10<sup>7&nbsp;</sup>cells. Also, the enrollment target has been increased to up to 140 subjects.</li><li>It has also amended the protocol in its Phase 1 study, CRB-401, evaluating bb2121 in relapsed/refractory MM. Enrollment will be increased by up to 20 subjects and the dose range will be the same as KarMMa.</li><li>Celgene and licensor bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) continue to expect regulatory approval for bb2121 in MM in 2020.</li><li>CELG is up a fraction and BLUE is down a fraction after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342156-celgene-bluebird-bio-team-develop-commercialize-car-t-bb2121\" target=\"_blank\">Celgene and bluebird bio team up to develop and commercialize CAR T bb2121</a> (March 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316572-celgene-launches-mid-stage-study-car-t-candidate-bb2121\" target=\"_blank\">Celgene launches mid-stage study of CAR-T candidate bb2121</a> (Dec. 6, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369854\" data-linked=\"Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myeloma\" data-tweet=\"$CELG $CELG $BLUE - Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myeloma https://seekingalpha.com/news/3369854-celgene-ups-dose-and-enrollment-in-mid-stage-study-of-bb2121-in-multiple-myeloma?source=tweet\" data-url=\"https://seekingalpha.com/news/3369854-celgene-ups-dose-and-enrollment-in-mid-stage-study-of-bb2121-in-multiple-myeloma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369839\" data-ts=\"1531431203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369839-after-hours-gainers-losers-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (07/12/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='green'>+4.9%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='green'>+3.4%</font>. <a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a> <font color='green'>+1.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/INGR' title='Ingredion, Inc.'>INGR</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a> <font color='red'>-2.2%</font>. <a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a> <font color='red'>-1.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369839\" data-linked=\"After Hours Gainers / Losers (07/12/2018)\" data-tweet=\"$GOGO $GOGO $BBD - After Hours Gainers / Losers (07/12/2018) https://seekingalpha.com/news/3369839-after-hours-gainers-losers-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369839-after-hours-gainers-losers-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369840\" data-ts=\"1531430987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INGR\" target=\"_blank\">INGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369840-ingredionminus-4_3-on-forecast-cut-cost-savings-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ingredion -4.3% on forecast cut, cost-savings program</a></h4><ul>   <li>Ingredion (NYSE:<a href='https://seekingalpha.com/symbol/INGR' title='Ingredion, Inc.'>INGR</a>) is <font color='red'>4.3% lower</font> after hours after <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=77278&amp;p=irol-newsArticle_print&amp;ID=2358120\" target=\"_blank\">cutting its forecast and launching a $125M cost savings program</a>.</li>    <li>In preliminary Q2 results, it sees adjusted EPS of $1.63-$1.68 (below consensus for $1.92), with expected weakness in North America (where it saw lower than expected sweetener volumes sold into beverages, and higher manufacturing costs).</li>    <li>It's cutting full-year EPS guidance to $7.50-$7.80 from a previous $7.90-$8.20 (and below consensus for $7.92).</li>    <li>The company's forecast for adjusted cash flow from operations is $800M-$850M.</li>    <li>In cost savings, it's ceasing wet-milling operations in Stockton, Calif., and will establish a distribution station by the end of the year to distribute to the Western U.S. \"We're taking this necessary action to balance our capacity versus sweetener demand, focus future resource investment toward our specialty growth initiatives, and continue to deliver on our customer experience commitments,\" says CEO Jim Zallie.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369840\" data-linked=\"Ingredion -4.3% on forecast cut, cost-savings program\" data-tweet=\"$INGR - Ingredion -4.3% on forecast cut, cost-savings program https://seekingalpha.com/news/3369840-ingredionminus-4_3-on-forecast-cut-cost-savings-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3369840-ingredionminus-4_3-on-forecast-cut-cost-savings-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369837\" data-ts=\"1531430674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369837-illinois-public-health-agency-probes-illnesses-linked-to-mcdonald-s-salads\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illinois public health agency probes illnesses linked to McDonald\u2019s salads</a></h4><ul>     <li>McDonald's (NYSE:<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a>)&nbsp;<font color='red'>-1.4%</font> after-hours on news that the Illinois Department of Public Health has launched an <a href=\"http://www.dph.illinois.gov/news/idph-investigating-increase-foodborne-illnesses\" target=\"_blank\">investigation into foodborne illnesses</a> in the company's salads.</li>     <li>The IDPH says it has received confirmation of ~90 cases of cyclosporiasis, an intestinal illness caused by a microscopic parasite, and around a quarter of the cases reported eating salads from McDonald&rsquo;s in the days before they became ill.</li>     <li>The agency says MCD is in the process of removing the salads from its Illinois restaurants and distribution centers, and will re-supply restaurants with salads from other suppliers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369837\" data-linked=\"Illinois public health agency probes illnesses linked to McDonald\u2019s salads\" data-tweet=\"$MCD - Illinois public health agency probes illnesses linked to McDonald\u2019s salads https://seekingalpha.com/news/3369837-illinois-public-health-agency-probes-illnesses-linked-to-mcdonald-s-salads?source=tweet\" data-url=\"https://seekingalpha.com/news/3369837-illinois-public-health-agency-probes-illnesses-linked-to-mcdonald-s-salads\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369832\" data-ts=\"1531429896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369832-intelsat-stocks-bonds-jump-fcc-advances-mid-band-proposal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat stocks, bonds jump as FCC advances mid-band proposal</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) shares rose to a four-year high -- and its bonds were jumping -- after the FCC voted 4-0 to advance a proposal considering <a href=\"https://www.lightreading.com/mobile/5g/fcc-proposes-opening-more-spectrum-for-mid-band-5g/d/d-id/744651?_mc=RSS_LR_EDT\" target=\"_blank\">opening up mid-band spectrum</a> for use by wireless providers.</li>    <li>That's key to a proposal from Intelsat and SES (<a href='https://seekingalpha.com/symbol/SGBAF' title='Ses Global SA'>OTCPK:SGBAF</a>) and Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) to share that spectrum between satellite firms and wireless carriers to accelerate 5G development.</li>    <li>Intelsat closed <font color='green'>up 12.5%</font> on the NYSE; it's now <font color='green'>up 387%</font> since April 4.</li>    <li><a href='https://seekingalpha.com/symbol/SGBAF' title='Ses Global SA'>OTCPK:SGBAF</a> was <font color='green'>up 3.3%</font>; <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>up 2.2%</font>.</li>    <li>Meanwhile, Intelsat's 8.125% bonds due 2023 hit a three-year high, and Bloomberg notes they were the most traded U.S. junk bonds today. The bonds, rating CA/CCC-, rose 2.25 cents to $0.84, to yield 12.612%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369832\" data-linked=\"Intelsat stocks, bonds jump as FCC advances mid-band proposal\" data-tweet=\"$I $I $SGBAF - Intelsat stocks, bonds jump as FCC advances mid-band proposal https://seekingalpha.com/news/3369832-intelsat-stocks-bonds-jump-fcc-advances-mid-band-proposal?source=tweet\" data-url=\"https://seekingalpha.com/news/3369832-intelsat-stocks-bonds-jump-fcc-advances-mid-band-proposal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369829\" data-ts=\"1531429663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369829-gogoplus-6_6-on-restructuring-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo +6.6% on restructuring plan</a></h4><ul><li>        Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) <a href=\"https://seekingalpha.com/pr/17215258-gogo-announces-gogo-2020-integrated-business-plan-transform-business-model-realize-strategic\" target=\"_blank\">announces</a> a restructuring plan called Gogo 2020 that&rsquo;s meant to &ldquo;significantly reduce its cost structure, improve quality, drive revenue, streamline business processes and prudently strengthen its balance sheet.&rdquo;</li><li>               The company targets break-even FCF for 2020 and significant annual EBITDA growth each year to reach over $200M in 2022.&nbsp;</li><li>               Gogo wants to reduce total operating spend in its Commercial Aviation business by nearly 20% in the next two years and hopes to reduce cash burn next year by over $100M with a further $100M down in 2020.&nbsp;</li><li>               FY18 guidance: Total revenue $865M to $935M (in line with prior guidance), gross capex of $150 to $170M and cash capex of $110M and $130M. 2Ku incremental aircraft on-line expected at the low end of the prior guidance range of 550 to 650.&nbsp;</li><li>               Gogo shares are&nbsp;<font color='green'>up 6.6%</font>&nbsp;aftermarket to $5.17.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369829\" data-linked=\"Gogo +6.6% on restructuring plan\" data-tweet=\"$GOGO - Gogo +6.6% on restructuring plan https://seekingalpha.com/news/3369829-gogoplus-6_6-on-restructuring-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3369829-gogoplus-6_6-on-restructuring-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369818\" data-ts=\"1531427511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNKO\" target=\"_blank\">FNKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369818-funko-up-on-pokemon-licensing-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Funko up on Pokémon licensing agreement</a></h4><ul><li>        The Pok&eacute;mon Company and Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) <a href=\"https://seekingalpha.com/pr/17215158-pokemon-funko-team-launch-first-ever-pop-pokemon-figure\" target=\"_blank\">announce</a> their first collaboration and licensing agreements to bring Pok&eacute;mon Pop! figures to stores this summer.</li><li>               The first 4-inch figure is Pikachu and will launch on July 29. A 10-inch version will release later this year.&nbsp;</li><li>               Funko shares closed today&nbsp;<font color='green'>up 12.3%</font>&nbsp;and are up&nbsp;<font color='green'>0.9%&nbsp;</font>aftermarket to $15.35.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369818\" data-linked=\"Funko up on Pokémon licensing agreement\" data-tweet=\"$FNKO - Funko up on Pokémon licensing agreement https://seekingalpha.com/news/3369818-funko-up-on-pokemon-licensing-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3369818-funko-up-on-pokemon-licensing-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369794\" data-ts=\"1531425833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBW\" target=\"_blank\">BBW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369794-build-bear-pulls-promotion-early-due-to-huge-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Build-A-Bear pulls promotion early due to huge lines</a></h4><ul> <li>Build-A-Bear Workshop (NYSE:<a href='https://seekingalpha.com/symbol/BBW' title='Build-A-Bear Workshop, Inc.'>BBW</a>) pulled the plug on the retailer's \"pay your age\" promotion only after hours after it started due to huge crowds at stores.</li> <li>Build-A-Bear <a href=\"https://www.facebook.com/Buildabear/photos/a.94025970165.120723.8783725165/10156764264665166/?type=3&amp;theater\" target=\"_blank\">statement</a>: \"Per local authorities, we cannot accept additional Guests at our locations due to crowds and safety concerns. We have closed lines in our U.S. and Canada stores. We understand some Guests are disappointed and we will reach out directly as soon as possible.\"</li> <li>Shares of Build-A-Bear ended the day <font color='green'>up 1.94%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369794\" data-linked=\"Build-A-Bear pulls promotion early due to huge lines\" data-tweet=\"$BBW - Build-A-Bear pulls promotion early due to huge lines https://seekingalpha.com/news/3369794-build-bear-pulls-promotion-early-due-to-huge-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3369794-build-bear-pulls-promotion-early-due-to-huge-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369788\" data-ts=\"1531425728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIBH\" target=\"_blank\">CIBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369788-cib-marine-bancshares-slip-after-q2-eps-falls-to-2-cents-share-from-3-cents-y-y\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIB Marine Bancshares slip after Q2 EPS falls to 2 cents a share from 3 cents Y/Y</a></h4><ul><li>Thinly traded CIB Marine Bancshares (<a href='https://seekingalpha.com/symbol/CIBH' title='CIB Marine Bancshares, Inc.'>OTCQB:CIBH</a>)&nbsp;<font color='red'>slips 3.4%</font>&nbsp;after reporting Q2 EPS of 2 cents a share from 3 cents a year earlier.</li><li>Q2 net interest margin was 3.15% vs 3.20% in Q1 and 3.90% Y/Y.</li><li>Earnings on average equity was 3.41% vs 2.89% in Q1 and 5.71% Y/Y.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17215103-cib-marine-bancshares-inc-announces-2018-second-quarter-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369784-cib-marine-bancshares-reports-q2-results\" target=\"_blank\">CIB Marine Bancshares reports Q2 results</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369788\" data-linked=\"CIB Marine Bancshares slip after Q2 EPS falls to 2 cents a share from 3 cents Y/Y\" data-tweet=\"$CIBH - CIB Marine Bancshares slip after Q2 EPS falls to 2 cents a share from 3 cents Y/Y https://seekingalpha.com/news/3369788-cib-marine-bancshares-slip-after-q2-eps-falls-to-2-cents-share-from-3-cents-y-y?source=tweet\" data-url=\"https://seekingalpha.com/news/3369788-cib-marine-bancshares-slip-after-q2-eps-falls-to-2-cents-share-from-3-cents-y-y\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369786\" data-ts=\"1531425535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUO\" target=\"_blank\">ZUO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369786-software-stocks-gain-after-broadcoms-ca-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Software stocks gain after Broadcom&#39;s CA buyout offer</a></h4><ul><li>Software stocks had a good day following Broadcom&rsquo;s $18.9B buyout offer for CA.</li><li>On the move: Zuora (<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='green'>+6.8%</font>), MongoDB (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='green'>+8.7%</font>), DocuSign (<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a> <font color='green'>+6.4%</font>), Okta (<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a> <font color='green'>+6.7%</font>), Smartsheet (<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a> <font color='green'>+6.2%</font>), Carbon Black (<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black'>CBLK</a> <font color='green'>+8%</font>), New Relic (<a href='https://seekingalpha.com/symbol/NEWR' title='New Relic'>NEWR</a> <font color='green'>+4.8%</font>), Varonis Systems (<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a> <font color='green'>+5.1%</font>), Twilio (<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+4.5%</font>), Qualys (<a href='https://seekingalpha.com/symbol/QLYS' title='Qualys'>QLYS</a> <font color='green'>+4.1%</font>), Ceridian (<a href='https://seekingalpha.com/symbol/CDAY' title='Ceridian HCM Holding Inc.'>CDAY</a> <font color='green'>+5.9%</font>), Avalara (<a href='https://seekingalpha.com/symbol/AVLR' title='Avalara'>AVLR</a> <font color='green'>+3.6%</font>), Rapid7 (<a href='https://seekingalpha.com/symbol/RPD' title='Rapid7'>RPD</a> <font color='green'>+4.8%</font>), Dropbox (<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a> <font color='green'>+4.7%</font>), HubSpot (<a href='https://seekingalpha.com/symbol/HUBS' title='HubSpot, Inc.'>HUBS</a> <font color='green'>+3.6%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369508-broadcom-confirms-18_9b-buyout-ca\" target=\"_blank\">Broadcom confirms $18.9B buyout of CA</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369786\" data-linked=\"Software stocks gain after Broadcom&#39;s CA buyout offer\" data-tweet=\"$ZUO $ZUO $MDB - Software stocks gain after Broadcom&#39;s CA buyout offer https://seekingalpha.com/news/3369786-software-stocks-gain-after-broadcoms-ca-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3369786-software-stocks-gain-after-broadcoms-ca-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369778\" data-ts=\"1531424584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369778-ad-com-thumbs-up-on-glaxos-malaria-drug-tafenoquine-shares-up-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad Com thumbs up on Glaxo&#39;s malaria drug tafenoquine; shares up 1.5%</a></h4><ul><li>The FDA's <a href=\"https://www.fda.gov/AdvisoryCommittees/Calendar/ucm611950.htm\" target=\"_blank\">Antimicrobial Drugs Advisory Committee</a> voted 12-1 in favor of the safety profile of GlaxoSmithKline's (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='green'>+1.5%</font>) tafenoquine tablets for the radical cure (prevention of relapse) of malaria caused by <em>Plasmodium vivax</em>.</li><li>The committee voted 13-0 backing efficacy and, therefore, recommending approval.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369778\" data-linked=\"Ad Com thumbs up on Glaxo&#39;s malaria drug tafenoquine; shares up 1.5%\" data-tweet=\"$GSK - Ad Com thumbs up on Glaxo&#39;s malaria drug tafenoquine; shares up 1.5% https://seekingalpha.com/news/3369778-ad-com-thumbs-up-on-glaxos-malaria-drug-tafenoquine-shares-up-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3369778-ad-com-thumbs-up-on-glaxos-malaria-drug-tafenoquine-shares-up-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369780\" data-ts=\"1531423800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZK\" target=\"_blank\">OZK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369780-bank-of-ozarks-dives-9-day-cre-lending-competition-intensifies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of the Ozarks dives 9% day as CRE lending competition intensifies</a></h4><ul><li>Bank of the Ozarks (OZRK)--soon to be renamed Bank OZK--<font color='red'>skids 9%</font>&nbsp;in late afternoon trading after the bank warned that<a href=\"https://www.bloomberg.com/news/articles/2018-07-12/jpmorgan-wells-fargo-may-go-back-to-basics-with-loans-in-focus?utm_source=twitter&amp;cmpid%3D=socialflow-twitter-markets&amp;utm_medium=social&amp;utm_campaign=socialflow-organic&amp;utm_content=markets\" target=\"_blank\"> competition in commercial real estate business,</a> its biggest loan sector, is getting more aggressive in terms of credit structures and pricing.</li><li>The S&amp;P 500 Regional Banks Sub-Industry Index<font color='red'> fell 0.65%.</font></li><li>Other regional banks dipping this afternoon: M&amp;T Bank (<a href='https://seekingalpha.com/symbol/MTB' title='M&T Bank Corporation'>MTB</a> <font color='red'>-1.2%</font>), Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='red'>-1%</font>), Huntington Bancshares (<a href='https://seekingalpha.com/symbol/HBAN' title='Huntington Bancshares Incorporated'>HBAN</a> <font color='red'>-0.6%</font>), and KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='red'>-0.7%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369466-bank-ozark-falls-even-q2-nii-reaches-record\" target=\"_blank\">Bank of Ozark falls even as Q2 NII reaches record</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369780\" data-linked=\"Bank of the Ozarks dives 9% day as CRE lending competition intensifies\" data-tweet=\"$OZK $OZK $MTB - Bank of the Ozarks dives 9% day as CRE lending competition intensifies https://seekingalpha.com/news/3369780-bank-of-ozarks-dives-9-day-cre-lending-competition-intensifies?source=tweet\" data-url=\"https://seekingalpha.com/news/3369780-bank-of-ozarks-dives-9-day-cre-lending-competition-intensifies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369776\" data-ts=\"1531423254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369776-intel-acquires-easic-for-structured-asics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel acquires eASIC for structured ASICs</a></h4><ul><li>        Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <a href=\"https://seekingalpha.com/pr/17215070-intel-editorial-intel-acquire-easic-adding-programmable-solutions-talent-capabilities\" target=\"_blank\">will acquire</a> custom chipmaker eASIC for undisclosed terms.</li><li>               California-based eASIC provides structured application-specific integrated circuits (or ASICs), which offer better performance optimization and power efficiency than FPGAs.&nbsp;</li><li>               The acquisition will join Intel&rsquo;s Programmable Solutions Group.&nbsp;</li><li>               Intel expects the deal to close in Q3.&nbsp;</li><li>               Intel shares are&nbsp;<font color='green'>up 2.2%</font>&nbsp;to $52.34.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369776\" data-linked=\"Intel acquires eASIC for structured ASICs\" data-tweet=\"$INTC - Intel acquires eASIC for structured ASICs https://seekingalpha.com/news/3369776-intel-acquires-easic-for-structured-asics?source=tweet\" data-url=\"https://seekingalpha.com/news/3369776-intel-acquires-easic-for-structured-asics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369774\" data-ts=\"1531422898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369774-wsj-sec-probing-facebook-on-timing-of-data-leak-disclosures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: SEC probing Facebook on timing of data-leak disclosures</a></h4><ul>   <li>The <a href=\"https://www.wsj.com/articles/sec-probes-why-facebook-didnt-warn-sooner-on-privacy-lapse-1531422043\" target=\"_blank\">SEC is investigating</a> whether Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='green'>+1.8%</font>) gave adequate warnings to its investors about data leaks like the one central to the Cambridge Analytica scandal, <i>The Wall Street Journal</i> reports.</li>    <li>The probe is in its early stages, and the SEC is currently trying to get information about how much Facebook knew about Cambridge Analytica's use of the user data, and how it assessed the risk it faced from developers sharing data.</li>    <li>The investigation is likely turning on whether Facebook should have disclosed to investors knowledge of the Cambridge violation in 2015, when it learned about Aleksandr Kogan improperly sharing the data.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369774\" data-linked=\"WSJ: SEC probing Facebook on timing of data-leak disclosures\" data-tweet=\"$FB - WSJ: SEC probing Facebook on timing of data-leak disclosures https://seekingalpha.com/news/3369774-wsj-sec-probing-facebook-on-timing-of-data-leak-disclosures?source=tweet\" data-url=\"https://seekingalpha.com/news/3369774-wsj-sec-probing-facebook-on-timing-of-data-leak-disclosures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369771\" data-ts=\"1531421705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNTF\" target=\"_blank\">CNTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369771-technology-top-5-gainers-losers-of-2_55-pm-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (07/12/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='green'>+72%</font>. <a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ACMR' title='ACM Research, Inc.'>ACMR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a> <font color='green'>+11%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369771\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (07/12/2018)\" data-tweet=\"$CNTF $CNTF $CA - Technology - Top 5 Gainers / Losers as of 2.55 PM (07/12/2018) https://seekingalpha.com/news/3369771-technology-top-5-gainers-losers-of-2_55-pm-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369771-technology-top-5-gainers-losers-of-2_55-pm-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369769\" data-ts=\"1531421649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369769-cnbc-facebook-closes-loophole-exposing-private-group-details\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Facebook closes loophole exposing private group details</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+2.1%</font>) has recently closed a loophole in its systems that allowed third parties to discover and harvest <a href=\"https://www.cnbc.com/2018/07/11/facebook-private-groups-breast-cancer-privacy-loophole.html\" target=\"_blank\">names of people in private Facebook Groups</a>, CNBC says.</li>    <li>A Chrome plug-in made for marketers to gather such information was shut down before Facebook's move when the company pressed the application's makers, Facebook says.</li>    <li>Members of private group for women with the BRCA gene mutation associated with a higher risk of breast cancer noticed that the Grouply.io Chrome extension allowed easy mass download of names, employers, locations, email addresses and other personal details of all 9,000 group members.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369769\" data-linked=\"CNBC: Facebook closes loophole exposing private group details\" data-tweet=\"$FB - CNBC: Facebook closes loophole exposing private group details https://seekingalpha.com/news/3369769-cnbc-facebook-closes-loophole-exposing-private-group-details?source=tweet\" data-url=\"https://seekingalpha.com/news/3369769-cnbc-facebook-closes-loophole-exposing-private-group-details\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369767\" data-ts=\"1531420930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGVC\" target=\"_blank\">NGVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369767-natural-grocers-runs-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural Grocers runs to 52-week high</a></h4><ul><li>Natural Grocers (<a href='https://seekingalpha.com/symbol/NGVC' title='Natural Grocers'>NGVC</a> <font color='green'>+15.3%</font>) rallies to a 52-week high of $2.06.</li><li>Seeking Alpha contributor Stephen Simpson posted a <a href=\"https://seekingalpha.com/article/4184078-natural-grocers-strong-traffic-margin-follow-crucial\" target=\"_blank\">deep dive</a> last month on the balancing act the company is facing with traffic and pricing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369767\" data-linked=\"Natural Grocers runs to 52-week high\" data-tweet=\"$NGVC - Natural Grocers runs to 52-week high https://seekingalpha.com/news/3369767-natural-grocers-runs-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3369767-natural-grocers-runs-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369760\" data-ts=\"1531419219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369760-cnbc-amazon-xealth-plan-healthcare-delivery-pilot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Amazon, Xealth plan healthcare delivery pilot</a></h4><ul><li>        <a href=\"https://www.cnbc.com/2018/07/11/amazon-providence-xealth-pilot-hospital-discharge.html\" target=\"_blank\">CNBC sources</a> say Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) and startup Xealth are planning a pilot program that would deliver doctor-recommended products after patients check out of the hospital.&nbsp;</li><li>               Patients would gain access to discounted medical supplies and goods with home delivery through Amazon Prime or other participating e-commerce providers.&nbsp;&nbsp;</li><li>        Xealth is managing the pilot with Amazon guiding bundle setup and reseller accounts. Seattle&rsquo;s Providence Health Systems and the University of Pittsburgh Medical Center are also onboard as both hospital systems and Xealth investors.</li><li>               The pilot program is under review and could start within months.&nbsp;</li><li>                  Amazon shares are&nbsp;<font color='green'>up 1.8%</font>&nbsp;to $1,786.04.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3369760\" data-linked=\"CNBC: Amazon, Xealth plan healthcare delivery pilot\" data-tweet=\"$AMZN - CNBC: Amazon, Xealth plan healthcare delivery pilot https://seekingalpha.com/news/3369760-cnbc-amazon-xealth-plan-healthcare-delivery-pilot?source=tweet\" data-url=\"https://seekingalpha.com/news/3369760-cnbc-amazon-xealth-plan-healthcare-delivery-pilot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369756\" data-ts=\"1531418423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TANH\" target=\"_blank\">TANH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369756-energy-materials-top-5-gainers-losers-of-2-00-pm-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NTIC' title='Northern Technologies International Corporation'>NTIC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369756\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/12/2018)\" data-tweet=\"$TANH $TANH $NTIC - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (07/12/2018) https://seekingalpha.com/news/3369756-energy-materials-top-5-gainers-losers-of-2-00-pm-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369756-energy-materials-top-5-gainers-losers-of-2-00-pm-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369750\" data-ts=\"1531417633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369750-information-huawei-plans-ai-chip-to-rival-nvidia-intel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Information: Huawei plans AI chip to rival Nvidia, Intel</a></h4><ul><li>        Huawei is making an artificial intelligence push that includes AI chips, according to <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">The Information</a> sources.&nbsp;</li><li>               The company&rsquo;s Project Da Vinci wants to bring AI to everything from telecom base stations to cloud data centers to smartphones to surveillance cameras.&nbsp;</li><li>               Huawei&rsquo;s telecom arm was effectively banned in the U.S. after a 2012 accusation that the company and ZTE had close ties to the Chinese government that could pose a national security threat.&nbsp;</li><li>               Earlier this year, U.S. lawmakers opposed Huawei&rsquo;s plan to sell a smartphone through AT&amp;T.&nbsp;</li><li>               Shares of AI chip rival Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) are&nbsp;<font color='green'>up 1.5%</font>&nbsp;to $251.19 and Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) is&nbsp;<font color='green'>up 1.9%</font>&nbsp;to $52.16.&nbsp;</li><li>               More movers: CEVA (<a href='https://seekingalpha.com/symbol/CEVA' title='CEVA, Inc.'>CEVA</a> <font color='green'>+0.6%</font>), which licenses tech to the chipmakers, and companies that supply software tools to chip engineers, Synopsys (<a href='https://seekingalpha.com/symbol/SNPS' title='Synopsys, Inc.'>SNPS</a> <font color='green'>+2.5%</font>) and Cadence Design Systems (<a href='https://seekingalpha.com/symbol/CDNS' title='Cadence Design Systems, Inc.'>CDNS</a> <font color='green'>+2%</font>).&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369750\" data-linked=\"The Information: Huawei plans AI chip to rival Nvidia, Intel\" data-tweet=\"$NVDA $NVDA $INTC - The Information: Huawei plans AI chip to rival Nvidia, Intel https://seekingalpha.com/news/3369750-information-huawei-plans-ai-chip-to-rival-nvidia-intel?source=tweet\" data-url=\"https://seekingalpha.com/news/3369750-information-huawei-plans-ai-chip-to-rival-nvidia-intel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369747\" data-ts=\"1531417372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPRO\" target=\"_blank\">SPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369747-small-bounce-for-spero-therapeutics-after-restructured-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small bounce for Spero Therapeutics after restructured capital raise</a></h4><ul><li>Spero (NASDAQ:<a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a>) plunged&nbsp;<font color='red'>nearly 25%</font>&nbsp;after announcing<a href=\"https://seekingalpha.com/news/3368742-spero-readies-stock-offering-shares-1-percent-hours\" target=\"_blank\"> a 4.5M share sale</a> of common stock after the close on Monday.</li><li>The company instead is <a href=\"https://seekingalpha.com/filing/4097538\" target=\"_blank\">offering just 3.25M</a> common shares, plus 2,166 shares of preferred stock, with each convertible into 1K common shares.</li><li>The stock's&nbsp;<font color='green'>up 3.5%</font>&nbsp;today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369747\" data-linked=\"Small bounce for Spero Therapeutics after restructured capital raise\" data-tweet=\"$SPRO - Small bounce for Spero Therapeutics after restructured capital raise https://seekingalpha.com/news/3369747-small-bounce-for-spero-therapeutics-after-restructured-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3369747-small-bounce-for-spero-therapeutics-after-restructured-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369744\" data-ts=\"1531416826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRI\" target=\"_blank\">TRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369744-thomson-reuters-launches-ai-enhanced-westlaw-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thomson Reuters launches AI-enhanced Westlaw offering</a></h4><ul>   <li>Thomson Reuters (<a href=\"http://seekingalpha.com/symbol/TRI\" target=\"_blank\">TRI</a> <font color='green'>+1.6%</font>) has introduced a new AI-enhanced platform to upgrade its <a href=\"https://seekingalpha.com/pr/17214366-thomson-reuters-unveils-new-legal-research-platform-advanced-ai-westlaw-edge\" target=\"_blank\">legal research offering</a>.</li>    <li>Westlaw Edge is the new version of Westlaw, the company says, adding capabilities including exclusive warnings for invalid or questionable law; an AI-improved WestSearch Plus search engine; Integrated Litigation Analytics to help guide trial strategy and inform timelines and budgets; and a tool to compare changes in statutory language.</li>    <li>\"We've been working with hundreds of attorneys to deeply understand how some research tasks can still take many hours to complete, as well as how mistakes are made, even by experienced lawyers,\" says Westlaw's Mike Dahn.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369744\" data-linked=\"Thomson Reuters launches AI-enhanced Westlaw offering\" data-tweet=\"$TRI - Thomson Reuters launches AI-enhanced Westlaw offering https://seekingalpha.com/news/3369744-thomson-reuters-launches-ai-enhanced-westlaw-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3369744-thomson-reuters-launches-ai-enhanced-westlaw-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369743\" data-ts=\"1531416599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369743-microsoft-hits-new-high-800b-market-cap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft hits new high, $800B market cap</a></h4><ul><li>        Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) shares hit a new all-time high of $104.29 midday before retreating slightly.</li><li>                  The company is still sitting about an $800B valuation, which puts it behind only Apple, Amazon, and Alphabet in market cap.    </li><li>               Microsoft shares are currently&nbsp;<font color='green'>up 2.2%</font>&nbsp;to $104.21.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369743\" data-linked=\"Microsoft hits new high, $800B market cap\" data-tweet=\"$MSFT - Microsoft hits new high, $800B market cap https://seekingalpha.com/news/3369743-microsoft-hits-new-high-800b-market-cap?source=tweet\" data-url=\"https://seekingalpha.com/news/3369743-microsoft-hits-new-high-800b-market-cap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369737\" data-ts=\"1531415468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LB\" target=\"_blank\">LB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369737-mall-retailers-fall-after-monthly-sales-reports-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mall retailers fall after monthly sales reports disappoint</a></h4><ul> <li>A brutal day in the apparel store sector is taking shape after monthly sales reports from L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-10.6%</font>), Cato (<a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='red'>-14.7%</font>), Zumiez (<a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color='red'>-11.7%</font>) and Buckle (<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='red'>-9.6%</font>) disappointed,</li> <li>Mall names being swept into the selling wave include American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='red'>-4.6%</font>), Ascena Retail Group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-3.2%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='red'>-3.2%</font>), Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='red'>-2.5%</font>), The Children's Place (<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a> <font color='red'>-2.1%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-2.4%</font>), Chico's FAS (<a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color='red'>-2.4%</font>) and Francesca's (<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='red'>-1.3%</font>).</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3369737\" data-linked=\"Mall retailers fall after monthly sales reports disappoint\" data-tweet=\"$LB $LB $CATO - Mall retailers fall after monthly sales reports disappoint https://seekingalpha.com/news/3369737-mall-retailers-fall-after-monthly-sales-reports-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3369737-mall-retailers-fall-after-monthly-sales-reports-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369735\" data-ts=\"1531415224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369735-cvs-and-aetna-rally-on-no-challenge-from-doj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CVS and Aetna rally on no challenge from DOJ</a></h4><ul><li>CVS Health (<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a> <font color='green'>+3.9%</font>) and Aetna (<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a> <font color='green'>+2.4%</font>) are rallying in apparent response to <a href=\"https://twitter.com/QTRResearch/status/1017452769865883649\" target=\"_blank\">reports </a>that the U.S. Department of Justice &#40;DOJ&#41; will not challenger their planned merger.</li><li>Merger partners Express Scripts (<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='green'>+2.3%</font>) and Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color='green'>+0.9%</font>) are up in concert as investors perceive bullish prospects for their tie-up.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369735\" data-linked=\"CVS and Aetna rally on no challenge from DOJ\" data-tweet=\"$CVS $CVS $AET - CVS and Aetna rally on no challenge from DOJ https://seekingalpha.com/news/3369735-cvs-and-aetna-rally-on-no-challenge-from-doj?source=tweet\" data-url=\"https://seekingalpha.com/news/3369735-cvs-and-aetna-rally-on-no-challenge-from-doj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369732\" data-ts=\"1531414857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPI\" target=\"_blank\">FPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369732-financials-top-gainers-losers-of-1-00-pm-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (07/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FPI' title='Farmland Partners Inc'>FPI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/PBSK' title='Poage Bankshares, Inc.'>PBSK</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> OZRK <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369732\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (07/12/2018)\" data-tweet=\"$FPI $FPI $PBSK - Financials - Top Gainers / Losers as of 1:00 PM (07/12/2018) https://seekingalpha.com/news/3369732-financials-top-gainers-losers-of-1-00-pm-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369732-financials-top-gainers-losers-of-1-00-pm-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369731\" data-ts=\"1531414744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369731-netflix-surpasses-hbo-to-lead-emmy-nominations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix surpasses HBO to lead Emmy nominations</a></h4><ul>   <li>Looking at the prestige side of the TV business a year after <a href=\"https://seekingalpha.com/news/3278515-cable-streaming-tv-services-take-lead-emmy-nominations\" target=\"_blank\">streaming services made major strides</a> in Emmy nominations, Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color='red'>-2.1%</font>) has surpassed HBO (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+1.1%</font>) in nominations for the first time, a comment on the company's enormous original-content budget and ambitions.</li>    <li>Netflix pulled 112 nominations to HBO's 108; last year, HBO had 110 nominations to Netflix's 91.</li>    <li>After missing the cutoff due to scheduling last year, HBO's <i>Game of Thrones</i> is <a href=\"https://variety.com/2018/tv/news/2018-emmy-nominations-scorecard-network-show-2-1202871469/\" target=\"_blank\">back in the running</a> and led all series with 22 nods, vs. 21 each for NBC's <i>Saturday Night Live</i> (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+1.7%</font>) and HBO's <i>Westworld.</i> (The latter two programs were last year's leaders with 22 nominations each.)</li>    <li>Just behind them was Hulu's breakout original hit <i>The Handmaid's Tale</i> with 20 nominations. (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>, <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-0.6%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-0.5%</font>, <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>).</li>    <li>NBC (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) led broadcast networks with 78 nominations, while FX (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>) had 50 nominations, most for basic cable. <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> had 34 nominations; ABC 31; Hulu 27 overall.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369731\" data-linked=\"Netflix surpasses HBO to lead Emmy nominations\" data-tweet=\"$CMCSA $CMCSA $DIS - Netflix surpasses HBO to lead Emmy nominations https://seekingalpha.com/news/3369731-netflix-surpasses-hbo-to-lead-emmy-nominations?source=tweet\" data-url=\"https://seekingalpha.com/news/3369731-netflix-surpasses-hbo-to-lead-emmy-nominations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369729\" data-ts=\"1531414604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDS\" target=\"_blank\">PDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369729-land-drillers-recommended-morgan-stanley-amid-permian-takeaway-risks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Land drillers recommended by Morgan Stanley amid Permian takeaway risks</a></h4><ul>     <li>Precision Drilling (<a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='green'>+3.1%</font>) and Nabors Industries (<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='red'>-0.8%</font>) are <a href=\"https://thefly.com/thestreet/realmoney/index.php/PDSid2757185/PDS-Morgan-Stanley-prefers-more-land-drilling-exposure-upgrades-Precision-Drilling\" target=\"_blank\">upgraded</a> to Overweight from Equal Weight at Morgan Stanley, which sees both companies continuing to realize strong pricing and activity levels in their U.S. land drilling businesses.</li>     <li>Given its expectation that Permian constraints will \"dominate the narrative\" through the Q2 earnings season and the belief that the Permian's regional weakness has potential to transmit to other basins, Stanley's Connor Lynagh recommends decreasing completions exposure as it increases land drilling exposure.</li><li>As a result, the firm downgrades C&amp;J Energy Services (<a href='https://seekingalpha.com/symbol/CJ' title='C&J Energy Services, Inc.'>CJ</a> <font color='green'>+1.5%</font>) and U.S. Silica (<a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica'>SLCA</a> <font color='red'>-1%</font>) to Equal Weight from Overweight and Superior Energy (<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='red'>-0.4%</font>) to Underweight from Equal Weight; it maintains Overweight ratings for Keane Group (<a href='https://seekingalpha.com/symbol/FRAC' title='Keane Group'>FRAC</a> <font color='green'>+0.8%</font>), FTS&nbsp;International (<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a> <font color='red'>-2.7%</font>), Liberty Oilfield Services (<a href='https://seekingalpha.com/symbol/LBRT' title='Liberty Oilfield Services Inc.'>LBRT</a> <font color='green'>+0.7%</font>) and Patterson-UTI Energy (<a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color='red'>-1.5%</font>).</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3369729\" data-linked=\"Land drillers recommended by Morgan Stanley amid Permian takeaway risks\" data-tweet=\"$PDS $PDS $NBR - Land drillers recommended by Morgan Stanley amid Permian takeaway risks https://seekingalpha.com/news/3369729-land-drillers-recommended-morgan-stanley-amid-permian-takeaway-risks?source=tweet\" data-url=\"https://seekingalpha.com/news/3369729-land-drillers-recommended-morgan-stanley-amid-permian-takeaway-risks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369727\" data-ts=\"1531413894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNTF\" target=\"_blank\">CNTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369727-midday-gainers-losers-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (07/12/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='green'>+70%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/FPI' title='Farmland Partners Inc'>FPI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/AMBO' title='Ambow Education Holding Ltd.'>AMBO</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/PBSK' title='Poage Bankshares, Inc.'>PBSK</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+14%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/SSLJ' title='SSLJ. COM LTD'>SSLJ</a> <font color='red'>-48%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='red'>-12%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369727\" data-linked=\"Midday Gainers / Losers (07/12/2018)\" data-tweet=\"$CNTF $CNTF $GLMD - Midday Gainers / Losers (07/12/2018) https://seekingalpha.com/news/3369727-midday-gainers-losers-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369727-midday-gainers-losers-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369719\" data-ts=\"1531412852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYAY\" target=\"_blank\">SKYAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369719-sky-hitting-18-year-highs-jefferies-boosts-target-on-bid-fight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sky hitting 18-year highs as Jefferies boosts target on bid fight</a></h4><ul>   <li>Sky (<a href='https://seekingalpha.com/symbol/SKYAY' title='Sky Plc ADR'>OTCPK:SKYAY</a>) is <font color='green'>up 3.6%</font> in OTC trading after the latest move in a bidding war for the UK broadcaster, a raised bid of $34B from Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+1.7%</font>).</li>    <li>Jefferies has given the stock a Street-high price target of &pound;17.50, up from &pound;16; that implies 13% upside from today's London close of &pound;15.45. Shares hit an 18-year high.</li>    <li>The firm sees Comcast's new bid as just the \"opening shot in an endgame,\" particularly considering Fox's (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-0.2%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-0.2%</font>) <a href=\"https://seekingalpha.com/news/3369568-britain-clears-way-foxs-sky-bid\" target=\"_blank\">clearance from the UK</a> for its own bid; Fox shouldn't count on completing its own deal with Disney and should be motivated to avoid losing the chance at control of Sky. (h/t Bloomberg)</li>    <li>Meanwhile, Macquarie has gone to Neutral on Sky with a price target of &pound;14.50, now implying 6.1% downside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369719\" data-linked=\"Sky hitting 18-year highs as Jefferies boosts target on bid fight\" data-tweet=\"$SKYAY $SKYAY $FOX - Sky hitting 18-year highs as Jefferies boosts target on bid fight https://seekingalpha.com/news/3369719-sky-hitting-18-year-highs-jefferies-boosts-target-on-bid-fight?source=tweet\" data-url=\"https://seekingalpha.com/news/3369719-sky-hitting-18-year-highs-jefferies-boosts-target-on-bid-fight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369716\" data-ts=\"1531412407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369716-drug-prices-still-marching-upward-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug prices still marching upward - Bloomberg</a></h4><ul><li>Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2018-07-12/drug-prices-keep-climbing-even-as-trump-steps-up-twitter-threats?utm_content=business&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;cmpid=socialflow-twitter-business&amp;utm_medium=social\" target=\"_blank\">reports </a>that, despite the recent concession from Pfizer to delay its price hikes until year-end, some drug makers are ignoring the political climate and instituting price increases now. Recent examples:</li><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+2%</font>): Revlimid +5% (+25% since Trump was elected).</li><li>Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='green'>+1.9%</font>): Victoza +7.9%.</li><li>Intercept Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>): Ocaliva +7.5%.</li><li>Acorda Therapeutics (<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-1%</font>): Ampyra +9.5%.</li><li>Astellas Pharma (<a href='https://seekingalpha.com/symbol/ALPMY' title='Astellas Pharma, Inc. ADR'>OTCPK:ALPMY</a> <font color='green'>+0.3%</font>): Vesicare +6%.</li><li>In a move that would make Martin Shkreli proud, Aytu BioScience (<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a> <font color='red'>-1.4%</font>), boosted the price of sleep drug Zolpimist by 724%. CEO Josh Disbrow says the drug was \"underpriced\" when acquired last month.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/PPH' title='VanEck Vectors Pharmaceutical ETF'>PPH</a> <font color='green'>+1%</font>)(<a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='green'>+2.8%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='green'>+0.9%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+3.3%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+1.6%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='green'>+1.6%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='green'>+1.4%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='green'>+3.4%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>)(VRX <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='green'>+1.7%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='green'>+0.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369716\" data-linked=\"Drug prices still marching upward - Bloomberg\" data-tweet=\"$CELG $CELG $NVO - Drug prices still marching upward - Bloomberg https://seekingalpha.com/news/3369716-drug-prices-still-marching-upward-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3369716-drug-prices-still-marching-upward-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369712\" data-ts=\"1531411255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNKO\" target=\"_blank\">FNKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369712-consumer-top-gainers-losers-of-12-00-pm-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (07/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BORN' title='China New Borun Corporation'>BORN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369712\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (07/12/2018)\" data-tweet=\"$FNKO $FNKO $LBIX-OLD - Consumer - Top Gainers / Losers as of 12:00 PM (07/12/2018) https://seekingalpha.com/news/3369712-consumer-top-gainers-losers-of-12-00-pm-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369712-consumer-top-gainers-losers-of-12-00-pm-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369708\" data-ts=\"1531410479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBO\" target=\"_blank\">AMBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369708-volatile-trading-on-ambow-education-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile trading on Ambow Education continues</a></h4><ul> <li>Shares of Ambow Education (NYSEMKT:<a href='https://seekingalpha.com/symbol/AMBO' title='Ambow Education Holding Ltd.'>AMBO</a>) <font color='green'>shoot up 22.02%</font> to break back over $6.00 for the first time in over four weeks.</li> <li>The trading range on Ambow has been between $3.97 and $8.00 since the IPO was priced at $4.25 on June 1.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3369708\" data-linked=\"Volatile trading on Ambow Education continues\" data-tweet=\"$AMBO - Volatile trading on Ambow Education continues https://seekingalpha.com/news/3369708-volatile-trading-on-ambow-education-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3369708-volatile-trading-on-ambow-education-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369698\" data-ts=\"1531408563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369698-jaguar-animal-health-up-22-on-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar Animal Health up 22% on Q2 results</a></h4><ul><li>Nano cap Jaguar Animal Health (<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='green'>+22.1%</font>) is up on a 4x surge in volume after <a href=\"https://www.sec.gov/Archives/edgar/data/1585608/000110465918044799/a18-17165_1ex99d1.htm\" target=\"_blank\">announcing</a>&nbsp;preliminary Q2 results. Key points:</li><li>Mytesi sales up 47% sequentially, up 125% in H1 yoy.</li><li>Mytesi co-promotion deal with RedHill Biopharma ramping up, adding 36 new territories not covered by Napo force.</li><li>U.S. Napo salesforce up to 18.</li><li>Final Q2 results will be reported in mid-August.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369698\" data-linked=\"Jaguar Animal Health up 22% on Q2 results\" data-tweet=\"$JAGX - Jaguar Animal Health up 22% on Q2 results https://seekingalpha.com/news/3369698-jaguar-animal-health-up-22-on-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3369698-jaguar-animal-health-up-22-on-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369699\" data-ts=\"1531408544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPL\" target=\"_blank\">BPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369699-pennsylvania-puc-nixes-buckeye-partners-plan-to-partially-reverse-pipeline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pennsylvania PUC nixes Buckeye Partners&#39; plan to partially reverse pipeline</a></h4><ul>     <li>Buckeye Partners' (<a href='https://seekingalpha.com/symbol/BPL' title='Buckeye Partners L.P.'>BPL</a> <font color='green'>+2.1%</font>) petition to partially reverse the flow of a portion of its Laurel pipeline is <a href=\"https://www.reuters.com/article/us-buckeye-partners-pipeline-pennsylvani/pa-utility-commission-rejects-buckeye-plan-to-partially-reverse-pipeline-idUSKBN1K226D\" target=\"_blank\">rejected</a> by the Pennsylvania Public Utilities Commission.</li>     <li>The PUC agreed with a previous <a href=\"https://seekingalpha.com/news/3342665-pennsylvania-regulator-recommends-reversal-buckeyes-laurel-pipeline\" target=\"_blank\">administrative law judge opinion</a> that said the partial reversal would hurt east coast refiners and not benefit the public.</li>     <li>BPL had asked to reverse the flow in a western portion of the 350-mile pipeline to allow Midwest refiners such as Marathon Petroleum greater access to the Pittsburgh market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369699\" data-linked=\"Pennsylvania PUC nixes Buckeye Partners&#39; plan to partially reverse pipeline\" data-tweet=\"$BPL - Pennsylvania PUC nixes Buckeye Partners&#39; plan to partially reverse pipeline https://seekingalpha.com/news/3369699-pennsylvania-puc-nixes-buckeye-partners-plan-to-partially-reverse-pipeline?source=tweet\" data-url=\"https://seekingalpha.com/news/3369699-pennsylvania-puc-nixes-buckeye-partners-plan-to-partially-reverse-pipeline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369694\" data-ts=\"1531408122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEDS\" target=\"_blank\">LEDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369694-semileds-down-7_1-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SemiLEDs down 7.1% post Q3 results</a></h4><ul><li>SemiLEDs (<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-7.1%</font>) <u><a href=\"https://seekingalpha.com/pr/17213743-semileds-reports-third-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">reports Q3</a></u>&nbsp;revenue decrease of 5.7% Y/Y to $2M, but increased 30% Q/Q.</li><li>Gross margin was 8%, compared with -29% previous year.</li><li>Operating margin was -18%, compared with -80% in Q2 2018.</li><li>Cash &amp; equivalents was $3.7M (-5.1% Q/Q).</li><li>Q4 Outlook: Revenue of $1.9M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369449-semileds-reports-q3-results\" target=\"_blank\">SemiLEDs reports Q3 results</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369694\" data-linked=\"SemiLEDs down 7.1% post Q3 results\" data-tweet=\"$LEDS - SemiLEDs down 7.1% post Q3 results https://seekingalpha.com/news/3369694-semileds-down-7_1-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3369694-semileds-down-7_1-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369696\" data-ts=\"1531407925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TREE\" target=\"_blank\">TREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369696-lendingtree-defended-oppenheimer-still-cuts-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LendingTree defended by Oppenheimer; still cuts price target</a></h4><ul><li>LendingTree's (<a href='https://seekingalpha.com/symbol/TREE' title='LendingTree, Inc.'>TREE</a> <font color='green'>+2.5%</font>) product diversification and paid marketing competencies are under-appreciated by the market, writes Oppenheimer equity analysts in a note dated July 11.</li><li>Those two factors could generate high-20s variable marketing margin growth over the medium-term, the note says.</li><li>Furthermore, successfully executing digital mortgage initiatives could drive long-term consensus VMM estimates.</li><li>Oppenheimer reiterates outperform rating and trims price target to $320 from $370.</li><li>Revenue estimate cut by 1% for each of 2018 and 2019; Oppenheimer leaves 2018 and 2019 EBITDA estimates unchanged.</li><li>LendingTree reached its 52-week intraday high of $404.40 on Jan. 23, while it's 52-week low was July 13, 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366285-lendingtree-slides-8-percent-compass-point-downgrades-slowing-momentum\" target=\"_blank\">LendingTree slides 8% after Compass Point downgrades on slowing momentum</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369696\" data-linked=\"LendingTree defended by Oppenheimer; still cuts price target\" data-tweet=\"$TREE - LendingTree defended by Oppenheimer; still cuts price target https://seekingalpha.com/news/3369696-lendingtree-defended-oppenheimer-still-cuts-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3369696-lendingtree-defended-oppenheimer-still-cuts-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369692\" data-ts=\"1531407631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369692-healthcare-top-5-gainers-losers-of-11-00-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/AST' title='Asterias Biotherapeutics, Inc.'>AST</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369692\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/12/2018)\" data-tweet=\"$JAGX $JAGX $OPNT - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/12/2018) https://seekingalpha.com/news/3369692-healthcare-top-5-gainers-losers-of-11-00-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369692-healthcare-top-5-gainers-losers-of-11-00-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369691\" data-ts=\"1531407381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369691-wix-shutterfly-gain-apple-ends-photo-print-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wix, Shutterfly gain as Apple ends Photo Print Products</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) is <a href=\"https://9to5mac.com/2018/07/12/photo-print-products-discontinued/\" target=\"_blank\">discontinuing</a> its Photo Print Products service, which was integrated into iPhoto. A message in macOS 10.13.6 Photos says final orders for the service must be placed by September 30.</li><li>               Customers can instead download a third-party app supporting the Photos Projects extension. Apps include Wix (NASDAQ:<a href='https://seekingalpha.com/symbol/WIX' title='Wix.com'>WIX</a>), Shutterfly (NASDAQ:<a href='https://seekingalpha.com/symbol/SFLY' title='Shutterfly, Inc.'>SFLY</a>), and Mimeo Photos.&nbsp;</li><li>Another one down: Apple also <a href=\"https://www.theverge.com/2018/7/12/17564098/apple-2015-macbook-pro-stops-selling\" target=\"_blank\">ceases sales</a> of the 2015 MacBook Pro today following the announced Pro lineup updates.&nbsp;</li><li>               The 2015 model notably included a USB-A port, a full-size SD card slot, and was the last to feature a traditional keyboard. The keyboard led to a four-year extended service program.&nbsp;&nbsp;</li><li>Wix shares are&nbsp;<font color='green'>up 3.1%</font>&nbsp;to $107.45.</li><li>Shutterfly shares are&nbsp;<font color='green'>up 2%</font>&nbsp;to $90.78.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369638-apple-updates-macbook-pro-lineup-releases-external-gpu\" target=\"_blank\">Apple updates MacBook Pro lineup, releases external GPU</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369691\" data-linked=\"Wix, Shutterfly gain as Apple ends Photo Print Products\" data-tweet=\"$AAPL $AAPL $WIX - Wix, Shutterfly gain as Apple ends Photo Print Products https://seekingalpha.com/news/3369691-wix-shutterfly-gain-apple-ends-photo-print-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3369691-wix-shutterfly-gain-apple-ends-photo-print-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369690\" data-ts=\"1531407287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRNNF\" target=\"_blank\">HRNNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369690-hydro-one-s-entire-board-ceo-to-depart-in-deal-ontario-premier\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hydro One\u2019s entire board, CEO to depart in deal with Ontario premier</a></h4><ul>     <li>Hydro One (<a href='https://seekingalpha.com/symbol/HRNNF' title='Hydro One Ltd'>OTC:HRNNF</a> <font color='red'>-2.7%</font>) shares slump after the company's <a href=\"https://www.theglobeandmail.com/canada/article-entire-ontario-hydro-one-board-to-resign-ceo-to-step-down/\" target=\"_blank\">entire board resigns and CEO Mayo Schmidt retires</a>, succumbing to pressure from Ontario Premier Doug Ford for new leadership at the utility.</li>     <li>Paul Dobson, who joined the company in March as CFO, will serve as interim CEO until a permanent replacement is made.</li>     <li>The utility&rsquo;s board will be replaced by 10 new directors, four of which will be named by Ontario's government, which owns 47% of the utility that controls much of the province&rsquo;s electrical transmission system.</li>     <li>It is <a href=\"http://www.spokesman.com/stories/2018/jul/11/hydro-one-ceo-and-board-ousted-in-political-shakeu/\" target=\"_blank\">unclear</a> how the shakeup will affect Hydro One's planned takeover of Avista (<a href='https://seekingalpha.com/symbol/AVA' title='Avista Corporation'>AVA</a> <font color='red'>-2.7%</font>), which still must win approval from regulators in Washington, Idaho and Oregon after already receiving clearance in Alaska and Montana.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369690\" data-linked=\"Hydro One\u2019s entire board, CEO to depart in deal with Ontario premier\" data-tweet=\"$HRNNF $HRNNF $AVA - Hydro One\u2019s entire board, CEO to depart in deal with Ontario premier https://seekingalpha.com/news/3369690-hydro-one-s-entire-board-ceo-to-depart-in-deal-ontario-premier?source=tweet\" data-url=\"https://seekingalpha.com/news/3369690-hydro-one-s-entire-board-ceo-to-depart-in-deal-ontario-premier\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369689\" data-ts=\"1531407061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEAF\" target=\"_blank\">LEAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369689-canaccord-starts-leaf-group-buy-sees-27-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord starts Leaf Group at Buy, sees 27% upside</a></h4><ul>   <li>Canaccord Genuity has initiated Leaf Group (<a href=\"http://seekingalpha.com/symbol/LFGR\" target=\"_blank\">LFGR</a> <font color='red'>-1.6%</font>) at Buy with a bullish target.</li>    <li>The firm's price target is an above-average $14, implying 27% upside from today's lower price.</li>    <li>Shares have made major moves in the past two months, with <font color='green'>gains on the quarter at 56.6%</font>; that lifts the stock's 2018 improvement to <font color='green'>13.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369689\" data-linked=\"Canaccord starts Leaf Group at Buy, sees 27% upside\" data-tweet=\"$LEAF - Canaccord starts Leaf Group at Buy, sees 27% upside https://seekingalpha.com/news/3369689-canaccord-starts-leaf-group-buy-sees-27-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3369689-canaccord-starts-leaf-group-buy-sees-27-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369685\" data-ts=\"1531406218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNVA\" target=\"_blank\">RNVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369685-rennova-q2-revenue-up-114-shares-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rennova Q2 revenue up 114%; shares up 26%</a></h4><ul><li>Nano cap Rennova Health (<a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='green'>+26.3%</font>) is up on more than triple normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/17214647-rennova-health-gives-update-second-quarter\" target=\"_blank\">announcement </a>of a 114% increase in Q2 revenues to $3.42M. Growth was helped by the inclusion of the first month's revenues from its second hospital, acquired on June 1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369685\" data-linked=\"Rennova Q2 revenue up 114%; shares up 26%\" data-tweet=\"$RNVA - Rennova Q2 revenue up 114%; shares up 26% https://seekingalpha.com/news/3369685-rennova-q2-revenue-up-114-shares-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3369685-rennova-q2-revenue-up-114-shares-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369684\" data-ts=\"1531406196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369684-accentureplus-1-on-big-data-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture +1% on big data acquisition</a></h4><ul><li>        Accenture (NYSE:<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a>) <a href=\"https://seekingalpha.com/pr/17214692-accenture-acquires-kogentix-help-clients-run-legacy-analytics-applications-open-source\" target=\"_blank\">acquires</a> big data and AI services company Kogentix for undisclosed terms.</li><li>                  US-based Kogentix offers services to move long-standing applications to big data-friendly tech like Hadoop, Spark, and Python.    </li><li>                  The acquisition will help strengthen Accenture Applied Intelligence&rsquo;s data engineering business.    </li><li>               Kogentix employs nearly 220 data professionals and has offices in Illinois, California, India, Singapore, and Indonesia.&nbsp;</li><li>               Accenture shares are&nbsp;<font color='green'>up 1%</font>&nbsp;to $168. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369684\" data-linked=\"Accenture +1% on big data acquisition\" data-tweet=\"$ACN - Accenture +1% on big data acquisition https://seekingalpha.com/news/3369684-accentureplus-1-on-big-data-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3369684-accentureplus-1-on-big-data-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369679\" data-ts=\"1531405988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369679-eia-natural-gas-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Natural Gas Inventory</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+51</strong>&nbsp;Bcf vs. +55 Bcf consensus, +78 Bcf last week.</li><li>Futures&nbsp;<font color='red'>-0.46%</font>&nbsp;to $2.816.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369679\" data-linked=\"EIA Natural Gas Inventory\" data-tweet=\"$UNG $DGAZ $UGAZ - EIA Natural Gas Inventory https://seekingalpha.com/news/3369679-eia-natural-gas-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3369679-eia-natural-gas-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369676\" data-ts=\"1531405026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSA\" target=\"_blank\">NSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369676-national-storage-bounces-from-yesterdays-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Storage bounces from yesterday&#39;s drop</a></h4><ul><li>National Storage Affiliates (NYSE:<a href='https://seekingalpha.com/symbol/NSA' title='National Storage Affiliates Trust'>NSA</a>) regains about half of yesterday's decline in early trading. NSA<font color='green'> +1.5%</font>&nbsp;this morning after losing 3.8% yesterday when it sold 5.9M shares at about $30 each.</li><li>Yesterday, KeyCorp analyst T. Thomas also <a href=\"https://www.dispatchtribunal.com/2018/07/12/research-analysts-issue-forecasts-for-national-storages-fy2019-earnings-nsa.html\" target=\"_blank\">nudged up </a>his FY2019 EPS estimate for the real estate investment trust&nbsp; by a penny to $1.46 from prior forecast of $1.45.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369297-national-storage-falls-177m-capital-raise-simply-self-storage-deal\" target=\"_blank\">National Storage falls after $177M capital raise for Simply Self Storage deal</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369676\" data-linked=\"National Storage bounces from yesterday&#39;s drop\" data-tweet=\"$NSA - National Storage bounces from yesterday&#39;s drop https://seekingalpha.com/news/3369676-national-storage-bounces-from-yesterdays-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3369676-national-storage-bounces-from-yesterdays-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369675\" data-ts=\"1531404996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSRGY\" target=\"_blank\">NSRGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369675-wpp-publicis-come-out-ahead-in-nestle-agency-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPP, Publicis come out ahead in Nestle agency review</a></h4><ul>   <li>Nestle has wrapped an advertising review by <a href=\"https://www.adweek.com/agencies/nestle-concludes-u-s-agency-review-by-consolidating-work-with-wpp-and-publicis/\" target=\"_blank\">consolidating work</a> with WPP (<a href=\"http://seekingalpha.com/symbol/WPP\" target=\"_blank\">WPP</a> <font color='green'>+2%</font>) and Publicis Groupe (<a href=\"http://seekingalpha.com/symbol/PUBGY\" target=\"_blank\">PUBGY</a> <font color='green'>+0.9%</font>).</li>    <li>The company doesn't comment on agency changes. The review covered multiple brands in the frozen meals, prepared foods, coffee and ice cream lines.</li>    <li>Interpublic Group (<a href=\"http://seekingalpha.com/symbol/IPG\" target=\"_blank\">IPG</a> <font color='green'>+0.1%</font>) also expanded its relationship with Nestle in the review.</li>    <li>The review was reportedly primarily to cut costs. Nestle (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>) spent about $619M on paid media in 2017, according to Kantar Media; its Q1 2018 budget was $140M (down $15M Y/Y).</li>    <li>Related: Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) <font color='green'>up 0.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369675\" data-linked=\"WPP, Publicis come out ahead in Nestle agency review\" data-tweet=\"$NSRGY $NSRGY $OMC - WPP, Publicis come out ahead in Nestle agency review https://seekingalpha.com/news/3369675-wpp-publicis-come-out-ahead-in-nestle-agency-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3369675-wpp-publicis-come-out-ahead-in-nestle-agency-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369672\" data-ts=\"1531404891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCRF\" target=\"_blank\">TSCRF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369672-thescore-down-4_4-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheScore down 4.4% post Q3 results</a></h4><ul><li>TheScore (<a href='https://seekingalpha.com/symbol/TSCRF' title='TheScore Inc'>OTC:TSCRF</a> <font color='red'>-4.4%</font>) <u><a href=\"https://seekingalpha.com/pr/17213764-thescore-reports-f2018-q3-results\" target=\"_blank\">reports Q3</a></u>&nbsp;revenue growth of 13.2% Y/Y to C$7.2M, the increase was due to strong performances from theScore's Canadian direct sales and US programmatic businesses.</li><li>EBITDA loss improved to C$44K, compared to a loss of C$2.2M the previous year.</li><li>Average monthly active users of theScore app on iOS were up 9% Y/Y.</li><li>Cash &amp; equivalents&nbsp;of C$7.9M.</li><li>\"This quarter also saw the legalization of sports betting in&nbsp;the United States, which presents an exciting opportunity for us. theScore is uniquely positioned to capitalize on this opportunity thanks to our mobile sports expertise, combined with our large and highly-engaged audience. We look forward to sharing more on our plans in due course.\" said&nbsp;John Levy, CEO and Founder of theScore.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369454-thescore-reports-q3-results\" target=\"_blank\">TheScore reports Q3 results</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369672\" data-linked=\"TheScore down 4.4% post Q3 results\" data-tweet=\"$TSCRF - TheScore down 4.4% post Q3 results https://seekingalpha.com/news/3369672-thescore-down-4_4-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3369672-thescore-down-4_4-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369671\" data-ts=\"1531404845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369671-cnbc-qualcomm-walk-from-nxp-deal-on-july-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Qualcomm could walk from NXP deal on July 25</a></h4><ul><li>        CNBC&rsquo;s David Faber <a href=\"https://www.streetinsider.com/Mergers+and+Acquisitions/NXP+Semiconductors+%28NXPI%29+Deal+Likely+to+be+Terminated+if+No+Okd+by+July+25+-+CNBC/14394059.html\" target=\"_blank\">says</a> Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) could walk away from its NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) acquisition if Chinese regulators don&rsquo;t approve the deal by the July 25 deadline.</li><li>               The deal&rsquo;s chances have ebbed with US-China relations souring again yesterday with the White House announcing plans for 10% tariffs on $200B in goods. &nbsp;&nbsp;</li><li>               NXP shares are&nbsp;<font color='red'>down 0.2%</font>&nbsp;to $107.35.&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='green'>up 1.6%</font>&nbsp;to $58.19.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367986-nanoxplore-announces-acquisition-sigma-industries\" target=\"_blank\">NanoXplore announces the acquisition of Sigma Industries</a> (July 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369289-white-house-tariff-plans-send-semi-stocks-sliding\" target=\"_blank\">White House tariff plans send semi stocks sliding</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369671\" data-linked=\"CNBC: Qualcomm could walk from NXP deal on July 25\" data-tweet=\"$QCOM $QCOM $NXPI - CNBC: Qualcomm could walk from NXP deal on July 25 https://seekingalpha.com/news/3369671-cnbc-qualcomm-walk-from-nxp-deal-on-july-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3369671-cnbc-qualcomm-walk-from-nxp-deal-on-july-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>107&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369656\" data-ts=\"1531404670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTIC\" target=\"_blank\">NTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369656-northern-technologies-up-5-on-q3-results-guidance-raised\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Technologies up 5% on Q3 results, guidance raised</a></h4><ul><li>Northern Technologies (<a href='https://seekingalpha.com/symbol/NTIC' title='Northern Technologies International Corporation'>NTIC</a> <font color='green'>+5.6%</font>) reported Q3 sales growth of 26.4% Y/Y to $12.92M reflecting increased sales of ZERUST&reg; industrial rust corrosion inhibiting packaging products, oil and gas products and Natur-Tec&reg; products.</li><li>Segment sales: ZERUST&reg; industrial $8.95M (24.8% Y/Y), ZERUST&reg; joint venture $879k (+2% Y/Y), ZERUST&reg; oil &amp; gas $555k (+65.6% Y/Y) and Natur-Tec&reg; $2.54M (+37% Y/Y).</li><li>Q3 overall margins: Gross&nbsp;<font color='red'>declined by 22 bps to</font>&nbsp;33.5% and operating&nbsp;<font color='green'>improved by 206 bps</font>&nbsp;to 18.9%.</li><li>Q3 operating expenses were up 16.2% Y/Y to $5.63M.</li><li>Company has cash and cash equivalents of $4.61M as of May 31, 2018.</li><li><strong>FY18 Guidance, raised</strong>: Sales $49.5-50.5M from $48-49M earlier and EPS $1.43-1.48 from $1.40-1.45 earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369597-northern-technologies-reports-q3-results\" target=\"_blank\">Northern Technologies reports Q3 results</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369656\" data-linked=\"Northern Technologies up 5% on Q3 results, guidance raised\" data-tweet=\"$NTIC - Northern Technologies up 5% on Q3 results, guidance raised https://seekingalpha.com/news/3369656-northern-technologies-up-5-on-q3-results-guidance-raised?source=tweet\" data-url=\"https://seekingalpha.com/news/3369656-northern-technologies-up-5-on-q3-results-guidance-raised\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369667\" data-ts=\"1531404512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369667-gw-pharma-claws-back-from-early-zogenix-stoked-selloff-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma claws back from early Zogenix-stoked selloff, up 2%</a></h4><ul><li>GW Pharmaceuticals (<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+1.6%</font>) is up on below-average volume. Shares were initially down&nbsp;<font color='red'>4%</font>&nbsp;on light volume before recovering.</li><li>Earlier today, Zogenix <a href=\"https://seekingalpha.com/news/3369561-zogenixs-zx008-successful-second-late-stage-study-dravet\" target=\"_blank\">reported </a>positive results from a second Phase 3 study of ZX008 (low-dose fenfluramine hydrochloride) in Dravet syndrome. The data from both studies will support marketing applications in the U.S. and Europe in Q4. ZX008 will compete against GW's Epidiolex (cannabidiol), <a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611046.htm\" target=\"_blank\">approved last month</a> in the U.S. for Dravet and Lennox-Gastaut syndromes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369667\" data-linked=\"GW Pharma claws back from early Zogenix-stoked selloff, up 2%\" data-tweet=\"$GWPH - GW Pharma claws back from early Zogenix-stoked selloff, up 2% https://seekingalpha.com/news/3369667-gw-pharma-claws-back-from-early-zogenix-stoked-selloff-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3369667-gw-pharma-claws-back-from-early-zogenix-stoked-selloff-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369655\" data-ts=\"1531403319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHCO\" target=\"_blank\">CHCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369655-city-holding-company-to-acquire-poage-bankshares-and-farmers-deposit-bancorp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">City Holding Company to acquire Poage Bankshares and Farmers Deposit Bancorp</a></h4><ul>     <li>City Holding Company (<a href='https://seekingalpha.com/symbol/CHCO' title='City Holding Company'>CHCO</a> <font color='red'>-3.8%</font>) announced the <a href=\"https://seekingalpha.com/pr/17213937-city-holding-company-announces-acquisitions-bolstering-kentucky-presence\" target=\"_blank\">concurrent signing of two separate definitive merger agreements</a> to acquire Poage Bankshares (<a href='https://seekingalpha.com/symbol/PBSK' title='Poage Bankshares, Inc.'>PBSK</a> <font color='green'>+22.2%</font>) and Farmers Deposit Bancorp.</li>     <li>Subject to the terms of the Poage merger agreement, Poage shareholders will receive 0.335 shares of City common stock for each outstanding share of Poage common stock. Based on City's 5-day average closing price of $78.43 as of July 10, 2018, this equates to a per share value of $26.27 and an aggregate deal value of $93.5M.</li>     <li>The combined company will have ~$4.8B in assets, deposits of ~$3.9B, and gross loans of ~$3.5B as of March 31, 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369655\" data-linked=\"City Holding Company to acquire Poage Bankshares and Farmers Deposit Bancorp\" data-tweet=\"$CHCO $CHCO $PBSK - City Holding Company to acquire Poage Bankshares and Farmers Deposit Bancorp https://seekingalpha.com/news/3369655-city-holding-company-to-acquire-poage-bankshares-and-farmers-deposit-bancorp?source=tweet\" data-url=\"https://seekingalpha.com/news/3369655-city-holding-company-to-acquire-poage-bankshares-and-farmers-deposit-bancorp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369651\" data-ts=\"1531403094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369651-acelrx-prices-stock-offering-2_75-shares-down-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AcelRx prices stock offering at $2.75; shares down 13%</a></h4><ul><li>AcelRx Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='red'>-13.2%</font>) <a href=\"https://seekingalpha.com/pr/17214665-acelrx-pharmaceuticals-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of ~7.3M shares of common stock at $2.75 per share. Underwriters over-allotment is an additional ~1.1M shares. Closing date is July 16.</li><li>Yesterday's close was $3.40.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369651\" data-linked=\"AcelRx prices stock offering at $2.75; shares down 13%\" data-tweet=\"$ACRX - AcelRx prices stock offering at $2.75; shares down 13% https://seekingalpha.com/news/3369651-acelrx-prices-stock-offering-2_75-shares-down-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3369651-acelrx-prices-stock-offering-2_75-shares-down-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369642\" data-ts=\"1531401826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369642-pareteum-rolls-out-customer-management-portal-for-clients\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum rolls out customer-management portal for clients</a></h4><ul>   <li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color='green'>up 1.7%</font> premarket on the announcement of a new <a href=\"https://seekingalpha.com/pr/17214419-pareteum-launches-revolutionary-cloud-based-self-service-portal-messaging-data-voice-services\" target=\"_blank\">self-service user portal</a> for its clients in managing customer information.</li>    <li>The aim is for application providers that need real-time transaction control to be able to manage customers' connections, usage and revenue stream.</li>    <li>Clients will have an ability to track authorized account users, create and manage credit limits and easily add peripheral products including video, applications and gaming.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369642\" data-linked=\"Pareteum rolls out customer-management portal for clients\" data-tweet=\"$TEUM - Pareteum rolls out customer-management portal for clients https://seekingalpha.com/news/3369642-pareteum-rolls-out-customer-management-portal-for-clients?source=tweet\" data-url=\"https://seekingalpha.com/news/3369642-pareteum-rolls-out-customer-management-portal-for-clients\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369635\" data-ts=\"1531401815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369635-sellas-prices-upsized-equity-offering-shares-down-25-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SELLAS prices upsized equity offering; shares down 25% premarket</a></h4><ul> <li>SELLAS Life Sciences Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>) has&nbsp;<a href=\"https://seekingalpha.com/pr/17214473-sellas-life-sciences-announces-pricing-upsized-24_2-million-public-offering\" target=\"_blank\">priced</a> its public offering of 11.52M shares of common stock and pre-funded warrants at a combined price of $2.10.</li>     <li>The offering is expected to close on or about July 16.</li>  <li>The company intends to use the net proceeds from the offering to commence a pivotal Phase 3 trial of GPS in acute myeloid leukemia, and to develop GPS in combination with pembrolizumab (Keytruda) in a Phase 1/2 proof of concept study, as well as for general corporate purposes and funding its working capital needs.</li><li>Yesterday's close was $2.32. Shares are down&nbsp;<font color='red'>25%</font>&nbsp;premarket on robust volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3369635\" data-linked=\"SELLAS prices upsized equity offering; shares down 25% premarket\" data-tweet=\"$SLS - SELLAS prices upsized equity offering; shares down 25% premarket https://seekingalpha.com/news/3369635-sellas-prices-upsized-equity-offering-shares-down-25-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369635-sellas-prices-upsized-equity-offering-shares-down-25-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369639\" data-ts=\"1531401655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSLJ\" target=\"_blank\">SSLJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369639-premarket-losers-of-9-05-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (07/12/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SSLJ' title='SSLJ. COM LTD'>SSLJ</a>&nbsp;<font color='red'>-38%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>&nbsp;<font color='red'>-23%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17214473-sellas-life-sciences-announces-pricing-upsized-24_2-million-public-offering\" target=\"_blank\">pricing</a> of upsized $24.2M public offering.</li>     <li><a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>&nbsp;<font color='red'>-19%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a>&nbsp;<font color='red'>-16%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a>&nbsp;<font color='red'>-14%&nbsp;</font>as SEC sends subpoena, <a href=\"https://seekingalpha.com/news/3369505-zion-oil-and-gas-minus-17-percent-sec-sends-subpoena-opens-investigation\" target=\"_blank\">opens investigation</a>.</li>     <li><a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>&nbsp;<font color='red'>-14%</font>&nbsp;on analyst <a href=\"https://seekingalpha.com/news/3369577-analysts-downgrade-broadcom-ca-buyout-offer\" target=\"_blank\">downgrade</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>&nbsp;<font color='red'>-13%</font>&nbsp;on equity <a href=\"https://seekingalpha.com/news/3369463-acelrx-initiates-equity-offering-shares-9-percent-hours\" target=\"_blank\">offering</a>.</li>     <li><a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>&nbsp;<font color='red'>-7%</font>&nbsp;after sales <a href=\"https://seekingalpha.com/news/3369574-l-brands-lower-sales-update\" target=\"_blank\">update</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369639\" data-linked=\"Premarket Losers as of 9:05 am (07/12/2018)\" data-tweet=\"$SSLJ $YGTY $SLS - Premarket Losers as of 9:05 am (07/12/2018) https://seekingalpha.com/news/3369639-premarket-losers-of-9-05-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369639-premarket-losers-of-9-05-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369634\" data-ts=\"1531401247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNTF\" target=\"_blank\">CNTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369634-premarket-gainers-of-9-05-07-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (07/12/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='green'>+119%</font>&nbsp;on entering into <a href=\"https://seekingalpha.com/news/3369529-techfaith-enters-agreement-sell-wholly-owned-subsidiary\" target=\"_blank\">agreement</a> to sell wholly-owned subsidiary.</li>     <li><a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a> <font color='green'>+25%</font>&nbsp;as ZX008 <a href=\"https://seekingalpha.com/news/3369561-zogenixs-zx008-successful-second-late-stage-study-dravet\" target=\"_blank\">successful</a> in second late-stage study in Dravet.</li>     <li><a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+21%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3369584-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li>     <li><a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a> <font color='green'>+18%</font>&nbsp;on Evercore <a href=\"https://seekingalpha.com/news/3369610-evercore-upgrades-ca-buyout-offer\" target=\"_blank\">upgrade</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17214428-chf-solutions-inc-enters-german-market\" target=\"_blank\">entering</a> into German market.</li>     <li><a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='green'>+14%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/FPI' title='Farmland Partners Inc'>FPI</a> <font color='green'>+13%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3369589-farmland-partners-bounces-nearly-14-percent-premarket-action\" target=\"_blank\">reversing</a> yesterday loss.</li>     <li><a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='green'>+11%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/BKYI' title='BIO-key International, Inc.'>BKYI</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3363337-asahi-cycle-co-enters-distribution-agreement-bio-keys-biometric-enabled-bicycle-locks\" target=\"_blank\">entering</a> distribution agreement for Bio-key's biometric enabled bicycle locks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369634\" data-linked=\"Premarket Gainers as of 9:05 am (07/12/2018)\" data-tweet=\"$CNTF $CNTF $ZGNX - Premarket Gainers as of 9:05 am (07/12/2018) https://seekingalpha.com/news/3369634-premarket-gainers-of-9-05-07-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3369634-premarket-gainers-of-9-05-07-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369633\" data-ts=\"1531401205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPNT\" target=\"_blank\">OPNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369633-opiant-pharma-up-20-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opiant Pharma up 20% premarket</a></h4><ul><li>Thinly traded nano cap Opiant Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a>) is up&nbsp;<font color='green'>20%</font>&nbsp;premarket on light volume. No particular news accounts for the action.</li><li>At the end of March, it had $11.3M in cash. Operations generated $2.2M in cash (driven by a $10M gain in accounts receivable) in Q1. In the last five months of 2017, operations consumed $3.8M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369633\" data-linked=\"Opiant Pharma up 20% premarket\" data-tweet=\"$OPNT - Opiant Pharma up 20% premarket https://seekingalpha.com/news/3369633-opiant-pharma-up-20-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369633-opiant-pharma-up-20-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369625\" data-ts=\"1531400104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369625-baird-says-intels-relationship-apple-is-well-alive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird says Intel&#39;s relationship with Apple is &quot;well alive&quot;</a></h4><ul><li>        Baird analyst Tristan Gerra <a href=\"https://www.streetinsider.com/Analyst+Comments/Baird+Sees+Intels+%28INTC%29+7560+Modem+Hitting+100%25+iPhone+Share+-+Baird/14392901.html\" target=\"_blank\">says</a> Intel&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) valuation remains attractive and checks show high yields of the 7560 model.</li><li>               Gerra says a 100% market share of the new iPhones is a renewed scenario for 2H, which reinforces his view that the relationship between Intel and Apple is &ldquo;well alive.&nbsp;&nbsp;</li><li>               Baird reiterates an Outperform rating and a $64 target, a 25% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Intel shares are&nbsp;<font color='green'>up 1%</font>&nbsp;premarket to $51.70.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3369625\" data-linked=\"Baird says Intel&#39;s relationship with Apple is &quot;well alive&quot;\" data-tweet=\"$INTC - Baird says Intel&#39;s relationship with Apple is &quot;well alive&quot; https://seekingalpha.com/news/3369625-baird-says-intels-relationship-apple-is-well-alive?source=tweet\" data-url=\"https://seekingalpha.com/news/3369625-baird-says-intels-relationship-apple-is-well-alive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369624\" data-ts=\"1531399977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369624-eyes-on-consumer-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eyes on consumer prices</a></h4><ul> <li>A couple of checks from today's report on consumer prices from the Bureau of Labor Statistics.</li> <li>Car and truck rental prices fell 7.6% Y/Y on an unadjusted basis. More trouble for <a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>, <a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a>, and <a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a>?</li> <li>Footwear prices dropped 1.3% Y/Y. Significant for <a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> and <a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a>?</li> <li>Women's outerwear decreased 4.3% Y/Y. Implications for <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>, <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>, <a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>, <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> and others.</li> <li>Egg prices jumped 14.1% Y/Y. Watch <a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a>.</li> <li>Coffee prices were down 2.7%, driven lower by a 6.1% decline in instant coffee. Heated battles for market share continue for <a href='https://seekingalpha.com/symbol/SJM' title='J. M. Smucker Company'>SJM</a>, <a href='https://seekingalpha.com/symbol/DNKN' title='Dunkin&#39; Brands'>DNKN</a>, <a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>, <a href='https://seekingalpha.com/symbol/KHC' title='The Kraft Heinz Company'>KHC</a> and <a href='https://seekingalpha.com/symbol/KDP' title='Keurig Dr Pepper Inc'>KDP</a>.</li> <li>Food away from home increased 2.8% Y/Y.</li> <li>Motor fuel costs rose 24.3% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369616-core-cpi-0_2-percent-june\" target=\"_blank\">Core CPI up 0.2% in June</a> (July 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369617-u-s-airline-fares-edge-lower\" target=\"_blank\">U.S. airline fares edge lower again</a> (July 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369624\" data-linked=\"Eyes on consumer prices\" data-tweet=\"$HTZ $HTZ $CAR - Eyes on consumer prices https://seekingalpha.com/news/3369624-eyes-on-consumer-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3369624-eyes-on-consumer-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369622\" data-ts=\"1531399802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGEN\" target=\"_blank\">SGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369622-mid-stage-study-underway-for-seattle-genetics-tisotumab-vedotin-in-solid-tumors-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mid-stage study underway for Seattle Genetics&#39; tisotumab vedotin in solid tumors; shares up 1% premarket</a></h4><ul><li>Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17214260-seattle-genetics-announces-first-patient-dosed-phase-2-innovatv-207-trial-evaluating\" target=\"_blank\">announcement </a>that the first patient has been dosed in a Phase 2 clinical trial, innovaTV 207, evaluating antibody-drug conjugate tisotumab vedotin as monotherapy in selected solid tumors with high Tissue Factor expression, a profile of cancer with a poor prognosis.</li><li><a href=\"https://clinicaltrials.gov/ct2/show/NCT03485209?term=tisotumab+vedotin&amp;rank=2\" target=\"_blank\">InnovaTV 207</a> is an open-label basket trial that will enroll up to 200 adult patients with relapsed, locally advanced/metastatic colorectal cancer, squamous non-small cell lung cancer, pancreatic adenocarcinoma or squamous cell cancer of the head and neck.</li><li>The primary endpoint is objective response rate through one month following the last dose. According to ClinicalTrials.gov, the estimated primary completion date is April 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369622\" data-linked=\"Mid-stage study underway for Seattle Genetics&#39; tisotumab vedotin in solid tumors; shares up 1% premarket\" data-tweet=\"$SGEN - Mid-stage study underway for Seattle Genetics&#39; tisotumab vedotin in solid tumors; shares up 1% premarket https://seekingalpha.com/news/3369622-mid-stage-study-underway-for-seattle-genetics-tisotumab-vedotin-in-solid-tumors-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3369622-mid-stage-study-underway-for-seattle-genetics-tisotumab-vedotin-in-solid-tumors-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369612\" data-ts=\"1531398305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYNE\" target=\"_blank\">ZYNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369612-zynerbas-zyn002-shows-positive-effect-in-mid-stage-fxs-study-shares-up-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynerba&#39;s ZYN002 shows positive effect in mid-stage FXS study; shares up 7% premarket</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17214203-zynerba-pharmaceuticals-announces-new-fab-c-phase-2-open-label-data-patients-fragile-x\" target=\"_blank\">Results </a>from an open-label Phase 2 clinical trial assessing Zynerba Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a>) ZYN002 in patients with Fragile X syndrome showed a treatment effect. The data are being presented at the International Fragile X Conference in Cincinnati, OH.</li><li>The results showed that treatment with ZYN002 statistically significantly improved core behavioral symptoms from baseline at week 12 and the improvements were sustained through 38 weeks of treatment.</li><li>ZYN002 was well-tolerated with no serious adverse events observed.</li><li>The company intends to submit the data for publication.</li><li>ZYN002 is a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced transdermal gel.</li><li>Shares are up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3348440-zynerbas-zyn002-show-positive-effect-focal-seizure-extension-study\" target=\"_blank\">Zynerba's ZYN002 show positive effect in focal seizure extension study</a> (April 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369612\" data-linked=\"Zynerba&#39;s ZYN002 shows positive effect in mid-stage FXS study; shares up 7% premarket\" data-tweet=\"$ZYNE - Zynerba&#39;s ZYN002 shows positive effect in mid-stage FXS study; shares up 7% premarket https://seekingalpha.com/news/3369612-zynerbas-zyn002-shows-positive-effect-in-mid-stage-fxs-study-shares-up-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369612-zynerbas-zyn002-shows-positive-effect-in-mid-stage-fxs-study-shares-up-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369610\" data-ts=\"1531398163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CA\" target=\"_blank\">CA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369610-evercore-upgrades-ca-after-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore upgrades CA after buyout offer</a></h4><ul><li>        Evercore ISI upgrades CA (NASDAQ:<a href='https://seekingalpha.com/symbol/CA' title='CA Inc.'>CA</a>) from Underperform to Inline.</li><li>               Price target gets a boost from $36 to $44.50, which was Broadcom&rsquo;s buyout offer and a nearly 20% premium to yesterday&rsquo;s close.&nbsp;</li><li>               CA shares are&nbsp;<font color='green'>up 18.3%</font>&nbsp;to $44.02.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369508-broadcom-confirms-18_9b-buyout-ca\" target=\"_blank\">Broadcom confirms $18.9B buyout of CA</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369610\" data-linked=\"Evercore upgrades CA after buyout offer\" data-tweet=\"$CA - Evercore upgrades CA after buyout offer https://seekingalpha.com/news/3369610-evercore-upgrades-ca-after-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3369610-evercore-upgrades-ca-after-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369608\" data-ts=\"1531398020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGL\" target=\"_blank\">EGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369608-reuters-defense-contractor-engility-explores-potential-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Defense contractor Engility explores potential sale</a></h4><ul>     <li>Engility Holdings (NYSE:<a href='https://seekingalpha.com/symbol/EGL' title='Engility Holdings'>EGL</a>)&nbsp;<font color='green'>+5%</font> premarket after Reuters reports the company is <a href=\"https://www.reuters.com/article/us-engility-hldg-m-a-sale-exclusive/exclusive-u-s-government-contractor-engility-explores-sale-sources-idUSKBN1K136O\" target=\"_blank\">exploring a sale</a>, attracting interest from government contracting peers such as CACI International (NYSE:<a href='https://seekingalpha.com/symbol/CACI' title='CACI International Inc'>CACI</a>) and Science Applications International (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>).</li>     <li>A sale would be the latest example of how increased defense spending under Pres. Trump is driving contractors to pursue mergers in order to gain scale to bid on bigger projects, Reuters writes.</li>     <li>Virginia-based EGL provides skilled personnel to U.S. departments of defense, homeland security and justice, among others.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369608\" data-linked=\"Reuters: Defense contractor Engility explores potential sale\" data-tweet=\"$EGL $EGL $CACI - Reuters: Defense contractor Engility explores potential sale https://seekingalpha.com/news/3369608-reuters-defense-contractor-engility-explores-potential-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3369608-reuters-defense-contractor-engility-explores-potential-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369607\" data-ts=\"1531397920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369607-goldman-ups-twitter-estimates-shares-gain-1_9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman ups Twitter estimates; shares gain 1.9% premarket</a></h4><ul><li>Checks suggest the impact of efforts to drive engagement through new features will outweigh concerns over the removal of fake accounts, says analyst Heath Terry. The Street, says Terry, also underestimates the company's ability to monetize engagement and show sizable operating expense leverage.</li><li>Terry lifts 2018-2020 revenue and adjusted EBITDA estimates by an average 4% and 6%, respectively.</li><li>Source: Bloomberg</li><li><a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a><font color='green'> +1.9%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3369607\" data-linked=\"Goldman ups Twitter estimates; shares gain 1.9% premarket\" data-tweet=\"$TWTR - Goldman ups Twitter estimates; shares gain 1.9% premarket https://seekingalpha.com/news/3369607-goldman-ups-twitter-estimates-shares-gain-1_9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369607-goldman-ups-twitter-estimates-shares-gain-1_9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369605\" data-ts=\"1531397713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369605-papa-johns-rallies-after-chairman-steps-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s rallies after chairman steps down</a></h4><ul> <li>Papa John's (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) is higher in early trading after the resignation of Chairman John Schnatter removes a significant overhang on the restaurant stock.</li> <li>The early indication from analysts is that Papa John's stands a good chance of re-invigorating the brand with the NFL-Schnatter flap now behind it.</li> <li>Shares of PZZA are <font color='green'>up 3.58%</font> in premarket trading to $50.06 vs. a 52-week range of $47.80 to $81.09. Over the last 52 weeks, Papa John's fell 36% in comparison to the 33% increase for Domino's Pizza.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3369518-papa-johns-founder-resigns-chairman\" target=\"_blank\">Papa John's founder resigns as chairman</a> (July 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3369605\" data-linked=\"Papa John&#39;s rallies after chairman steps down\" data-tweet=\"$PZZA - Papa John&#39;s rallies after chairman steps down https://seekingalpha.com/news/3369605-papa-johns-rallies-after-chairman-steps-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3369605-papa-johns-rallies-after-chairman-steps-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369582\" data-ts=\"1531396819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AST\" target=\"_blank\">AST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369582-asterias-bio-nabs-patent-rights-to-method-for-improving-recovery-in-stroke-patients-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asterias Bio nabs patent rights to method for improving recovery in stroke patients; shares up 13% premarket</a></h4><ul><li>Asterias Biotherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/AST' title='Asterias Biotherapeutics, Inc.'>AST</a>) secures <a href=\"https://seekingalpha.com/pr/17214141-asterias-biotherapeutics-announces-new-exclusive-license-agreement-regents-university\" target=\"_blank\">exclusive rights</a> to a patent family owned by the University of California for a method&nbsp;to improve recovery from ischemic stroke by administering patient stem cell-derived oligodendrocyte progenitor cells.</li>       <li>The deal supports the company's activities to explore the efficacy of AST-OPC1.</li><li>AST&nbsp;<font color='green'>+12.5%</font>&nbsp;premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3369582\" data-linked=\"Asterias Bio nabs patent rights to method for improving recovery in stroke patients; shares up 13% premarket\" data-tweet=\"$AST - Asterias Bio nabs patent rights to method for improving recovery in stroke patients; shares up 13% premarket https://seekingalpha.com/news/3369582-asterias-bio-nabs-patent-rights-to-method-for-improving-recovery-in-stroke-patients-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3369582-asterias-bio-nabs-patent-rights-to-method-for-improving-recovery-in-stroke-patients-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369584\" data-ts=\"1531396733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369584-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) initiated with Hold rating and $105 (11% upside) price target at Berenberg. Shares are up a fraction premarket.</li><li>Bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) initiated with Buy rating at Gabelli.</li><li>Galmed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>) initiated with Overweight rating and $59 (449% upside) price target at Cantor Fitzgerald citing bullish prospects for Aramchol. Shares up&nbsp;<font color='green'>30%</font>&nbsp;premarket.</li><li>Knight Therapeutics (<a href='https://seekingalpha.com/symbol/KHTRF' title='Knight Therapeutics Inc'>OTC:KHTRF</a>) initiated with Outperform rating at Raymond James.</li><li>Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) resumed with Overweight rating and $362 (15% upside) price target at Morgan Stanley.</li><li>MEDNAX (NYSE:<a href='https://seekingalpha.com/symbol/MD' title='Mednax, Inc.'>MD</a>) initiated with Market Perform rating and $50 (14% upside) price target at Leerink.</li><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) initiated with Buy rating and $30 (50% upside) price target at Seaport Global.</li><li>VolitionRx (NYSEMKT:<a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a>) initiated with Speculative Buy rating and $5 (138% upside) price target at Benchmark.</li><li>Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) upgraded to Neutral with a $134 (6% upside) price target at Goldman Sachs. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Perrigo (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a>) downgraded to Sell with a $74 (5% downside risk) price target at Goldman. Shares down&nbsp;<font color='red'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369584\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ABBV $ABBV $BLUE - Premarket analyst action - healthcare https://seekingalpha.com/news/3369584-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3369584-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369589\" data-ts=\"1531396503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPI\" target=\"_blank\">FPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369589-farmland-partners-bounces-nearly-14-in-premarket-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Farmland Partners bounces nearly 14% in premarket action</a></h4><ul><li>Farmland Partners (NYSE:<a href='https://seekingalpha.com/symbol/FPI' title='Farmland Partners Inc'>FPI</a>)&nbsp;<font color='green'>plunged 39%</font>&nbsp;yesterday after Seeking Alpha contributor Rota Fortunae <a href=\"https://seekingalpha.com/article/4186457-farmland-partners-loans-related-party-tenants-introduce-significant-risk-insolvency-shares\" target=\"_blank\">called out company management </a>for playing accounting games.</li><li>The company's CEO <a href=\"https://seekingalpha.com/news/3369506-farmland-partners-ceo-disputes-short-seller-allegations\" target=\"_blank\">denied the allegations</a> after the close, and this morning B. Riley's Craig Kucera upgrades to Buy from Neutral. He trimmed his price target to $8 from $8.50, but that's still&nbsp;<font color='green'>50% upside</font>&nbsp;from Wednesday's close.</li><li>There's fresh analysis on Seeking Alpha as well, with contributors <a href=\"https://seekingalpha.com/article/4186748-farmland-partners-meltdown-opportunity-trainwreck\" target=\"_blank\">Beyond Saving</a> and <a href=\"https://seekingalpha.com/article/4186777-farmland-partners-worth\" target=\"_blank\">Trapping Value</a> mulling the re-priced FPI.</li><li>Shares<font color='green'> up 13.6%</font>&nbsp;premarket to $6.00.</li></ul><div class=\"tiny-share-widget\" data-id=\"3369589\" data-linked=\"Farmland Partners bounces nearly 14% in premarket action\" data-tweet=\"$FPI - Farmland Partners bounces nearly 14% in premarket action https://seekingalpha.com/news/3369589-farmland-partners-bounces-nearly-14-in-premarket-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3369589-farmland-partners-bounces-nearly-14-in-premarket-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369578\" data-ts=\"1531395918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369578-longtime-ge-bear-heads-to-sidelines-shares-up-1_15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Longtime GE bear heads to the sidelines; shares up 1.15% premarket</a></h4><ul><li>The original Sell-rated bear in General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) has left the building, <a href=\"https://twitter.com/thenotablecalls/status/1017369398565376000\" target=\"_blank\">writes Notable Calls</a>, as Deutsche Bank upgrades to Hold.</li><li>Shares&nbsp;<font color='green'>up 1.15%&nbsp;</font>premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3369578\" data-linked=\"Longtime GE bear heads to the sidelines; shares up 1.15% premarket\" data-tweet=\"$GE - Longtime GE bear heads to the sidelines; shares up 1.15% premarket https://seekingalpha.com/news/3369578-longtime-ge-bear-heads-to-sidelines-shares-up-1_15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3369578-longtime-ge-bear-heads-to-sidelines-shares-up-1_15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369577\" data-ts=\"1531395681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369577-analysts-downgrade-broadcom-after-ca-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts downgrade Broadcom after CA buyout offer</a></h4><ul><li>        Evercore ISI <a href=\"https://www.streetinsider.com/Analyst+Comments/Evercore+ISI+Downgrades+Broadcom+Limited+%28AVGO%29+to+In+Line%3B+Investors+Likely+Disappointed+in+CA+Deal/14392679.html\" target=\"_blank\">downgrades</a> Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) from Outperform to Inline with a $275 price target, a 13% upside to yesterday&rsquo;s close. &nbsp;</li><li>        RBC <a href=\"https://www.streetinsider.com/Analyst+Comments/RBC+Capital+Downgrades+Broadcom+Limited+%28AVGO%29+to+Outperform%3B+Deal+Puts+Stock+in+Penalty+Box/14392829.html\" target=\"_blank\">downgrades</a> Broadcom from Top Pick to Outperform and lowers the price target from $330 to $300.</li><li>        The downgrades follow Broadcom&rsquo;s $18.9B buyout offer for CA.</li><li>               Broadcom shares are&nbsp;<font color='red'>down 8.9%</font>&nbsp;premarket to $221.70.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3369508-broadcom-confirms-18_9b-buyout-ca\" target=\"_blank\">Broadcom confirms $18.9B buyout of CA</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369577\" data-linked=\"Analysts downgrade Broadcom after CA buyout offer\" data-tweet=\"$AVGO - Analysts downgrade Broadcom after CA buyout offer https://seekingalpha.com/news/3369577-analysts-downgrade-broadcom-after-ca-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3369577-analysts-downgrade-broadcom-after-ca-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369576\" data-ts=\"1531395658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBSH\" target=\"_blank\">CBSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369576-commerce-bancshares-jumps-7-q2-earnings-rise-charge-offs-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commerce Bancshares jumps 7% as Q2 earnings rise, charge-offs decline</a></h4><ul><li>Commerce Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/CBSH' title='Commerce Bancshares Inc'>CBSH</a>) gains 7% in premarket trading after Q2 EPS beats estimates by 13% and net loan charge-offs fall to $10.0M from $10.8M Y/Y.</li><li>Q2 net income rose to $110.3M, or a record $1.01 per share, from $79M or 71 cents, Y/Y.</li><li>Q2 return on average common equity 16.78% vs 14.17% Y/Y.</li><li>Q2 net interest income increased $18.1M from Q1, but included an equity dividend of $8.9M this quarter, which was offset by a comparable securities loss; excluding this item, net interest margin grew 13 basis points thi quarter to 3.5%.</li><li>Fee income rose 8.2% Y/Y, driven by&nbsp;&nbsp;bank card, trust, swap and deposit fee income.</li><li>\"While total average loan balances were flat with the prior quarter, we experienced growth in our commercial and industrial, construction, and mortgage loan portfolios.,\" says Chairman and CEO&nbsp;David W. Kemper.&nbsp;</li><li>Consumer auto loan portfolio declined mostly as a result of a sale of $25.9M of auto loans to another financial institution this quarter.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17214068-commerce-bancshares-inc-reports-record-second-quarter-earnings-per-share-1_01\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3369551-commerce-bancshares-beats-0_12\" target=\"_blank\">Commerce Bancshares beats by $0.12</a> (July 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369576\" data-linked=\"Commerce Bancshares jumps 7% as Q2 earnings rise, charge-offs decline\" data-tweet=\"$CBSH - Commerce Bancshares jumps 7% as Q2 earnings rise, charge-offs decline https://seekingalpha.com/news/3369576-commerce-bancshares-jumps-7-q2-earnings-rise-charge-offs-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3369576-commerce-bancshares-jumps-7-q2-earnings-rise-charge-offs-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369561\" data-ts=\"1531394292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369561-zogenixs-zx008-successful-in-second-late-stage-study-in-dravet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zogenix&#39;s ZX008 successful in second late-stage study in Dravet</a></h4><ul><li>Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) <a href=\"https://seekingalpha.com/pr/17214165-zogenix-announces-positive-top-line-results-second-pivotal-phase-3-clinical-trial-zx008\" target=\"_blank\">announces </a>the successful outcome on a second Phase 3 clinical trial, Study 1504, evaluating ZX008 (low-dose fenfluramine hydrochloride) in children and young adults with rare and severe form of epilepsy called Dravet syndrome.</li><li>Patients in the treatment group experienced a 54.7% reduction in mean monthly convulsive seizures compared to placebo (p&lt;0.001). The median reduction in monthly convulsive seizure frequency was 62.7% versus 1.2% for placebo.</li><li>Both key secondary endpoints were also met. The safety profile was consistent with the first Phase 3, announced in September 2017.</li><li>Regulatory submissions in the U.S. and Europe are on tap for Q4.</li><li>Management will host a conference call this morning at 8:30 am ET to discuss the results.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298357-zogenixs-lead-candidate-zx008-successful-late-stage-dravet-study-shares-212-percent-premarket\" target=\"_blank\">Zogenix's lead candidate ZX008 successful in late-stage Dravet study; shares up 212% premarket</a> (Sept. 29, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3369561\" data-linked=\"Zogenix&#39;s ZX008 successful in second late-stage study in Dravet\" data-tweet=\"$ZGNX - Zogenix&#39;s ZX008 successful in second late-stage study in Dravet https://seekingalpha.com/news/3369561-zogenixs-zx008-successful-in-second-late-stage-study-in-dravet?source=tweet\" data-url=\"https://seekingalpha.com/news/3369561-zogenixs-zx008-successful-in-second-late-stage-study-in-dravet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369555\" data-ts=\"1531393322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKIS\" target=\"_blank\">SKIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369555-peak-resorts-misses-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peak Resorts misses by $0.06, beats on revenue</a></h4><ul><li>Peak Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/SKIS' title='Peak Resorts'>SKIS</a>): Q4 EPS of $0.56 <font color='red'>misses by $0.06</font>.</li><li>Revenue of $56.03M (+9.3% Y/Y) <font color='green'>beats by $3.28M</font>.</li><li>Shares <font color='green'>+6.6%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17214170-peak-resorts-reports-record-fiscal-2018-fourth-quarter-revenue'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3369555\" data-linked=\"Peak Resorts misses by $0.06, beats on revenue\" data-tweet=\"$SKIS - Peak Resorts misses by $0.06, beats on revenue https://seekingalpha.com/news/3369555-peak-resorts-misses-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3369555-peak-resorts-misses-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3369551\" data-ts=\"1531393003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBSH\" target=\"_blank\">CBSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3369551-commerce-bancshares-beats-0_12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commerce Bancshares beats by $0.12</a></h4><ul><li>Commerce Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/CBSH' title='Commerce Bancshares Inc'>CBSH</a>): Q2 EPS of $1.01 <font color=\"green\">beats by $0.12</font>.</li><li>Revenue of $335.81M (+12.6% Y/Y)</li><li>Shares <font color=\"green\">+6.9%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17214068-commerce-bancshares-inc-reports-record-second-quarter-earnings-per-share-1_01\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3369551\" data-linked=\"Commerce Bancshares beats by $0.12\" data-tweet=\"$CBSH - Commerce Bancshares beats by $0.12 https://seekingalpha.com/news/3369551-commerce-bancshares-beats-0_12?source=tweet\" data-url=\"https://seekingalpha.com/news/3369551-commerce-bancshares-beats-0_12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}